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”First they ignore you, then they laugh at you, then they fight you, then you win.”
Mahatma Ghandi
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ABSTRACT
Background 
The translational process of introducing a new tre-
atment concept in medicine from innovation to 
clinical application is a challenging endeavour that 
often involves animal experiments. Focal cartilage 
lesion remains a clinical challenge and is considered 
to portend osteoarthritis (OA). For the last 30 years 
biological treatment strategies have aimed to rege-
nerate a durable cartilage repair tissue. In the last 
decade a novel treatment strategy has been propo-
sed by surgically replacing the void of the cartilage 
defect with a metal implant, focal knee resurfacing 
with metal (FKRM) implants. 
Methods
We developed a double-radii, double-coated im-
plant with an individualised instrumentation device 
for optimal positioning. This concept was tested in 
a larger animal model (sheep) evaluating the biolo-
gical safety and efficacy of the implant. A total of 
37 ewes were used in the experiments of this thesis. 
Implant position was measured using a developed 
laser-scanning protocol. General animal health, 
general cartilage health and macroscopic as well 
as microscopic cartilage evaluation were assessed 
according to a modified Mankin score as recom-
mended by Osteoarthritis Research Society Interna-
tional (OARSI) for histological assessment of oste-
oarthritis in sheep. Osseointegration was evaluated 
histomorphometrically. A proposed classification of 
cartilage health adjacent to an implant was presen-
ted and implemented.
Results
Osseointegration was excellent, bone-to-implant 
contact was measured with a mean (95% confidence 
interval – CI) of 90.6% (79-102) at six months and 
92.3% (89-95) at twelve months, respectively. Im-
plant position correlated to opposing tibial cartilage 
damage, an implant should not protrude. Micros-
copic score as a function of implant position showed 
a linear relationship (P = 0.008) such that Mankin 
score increased by 4.3 units (95% CI: 1.5, 7.0) per 
each mm elevation in implant height. Using a dedica-
ted guide the general implant position was consistent 
and adequate, and was on average 0.54 mm reces-
sed (95% CI: 0.41, 0.67). Cartilage damage of the 
medial tibial plateau opposing the implant was in-
creased compared to the non-operated knee by 1.77 
units (P = 0.041; 95% CI: 0.08, 3.45) on a 0-27 
unit scale. Remaining joint compartments were 
unaffected. Cartilage health adjacent to the implant 
was satisfactory and Hydroxiapatite (HA) improves 
chondrointegration. Untreated critical size cartilage 
defects did not heal at six-month follow-up.
Conclusions
Focal knee resurfacing with metal implants is a safe 
and viable treatment option for full depth focal 
condylar cartilage lesions. Cartilage damage evalu-
ated microscopically was acceptable given implant 
position related to surrounding cartilage was opti-
mal. Implant position is of utmost importance and 
individualised implants and instrumentations devi-
ces are recommended. An implant should never sit 
proud. Clinical studies of symptomatic focal car-
tilage lesions are recommended but prior to prop-
hylactic treatment of asymptomatic patients more 
research is needed. 
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ABBREVIATIONS
AC  Articular Cartilage
ACI  Autologous Chondrocyte Implantation
B-SEM  Backscatter Electron Microscopy
CAD/CAM Computer-Aided Design/ Computer-Aided Manufacturing
Co – Cr Cobalt  – Chrome
FEA  Finite Element Analysis
FKR  Focal Knee Resurfacing
FKRM  Focal Knee Resurfacing with Metal implants
GAG  Glycosaminoglycan
HA  Hydroxyapatite
ICRS  International Cartilage Research Society
LM  Light Microscopy
Micro-CT Micro Computerised Tomography
MSC  Mesenchymal Stem Cells
OA  Osteoarthritis
OxZr  Oxidized Zirconium
PG  Proteoglycans
PMMA  Polymethylmethacrylate
SEM   Scanning Electron Microscopy
SPS  Spark Plasma Sintering
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DEFINITIONS
Artefacts 
Artefacts are structures or features in tissue that in-
terfere with normal histological examination.
Bone ingrowth 
New bone formation in intimate contact with the 
surface of the implant.
Critical size defect 
Minimum cartilage defect (in diameter) that is re-
pairable without intervention.
Finite Element analysis 
Numerical technique for finding solution to partial 
differential equations. Widely used in science as a 
computational tool for engineering analysis such as 
deformation of cars due to crashes.
Histomorphometry
Is the quantitative study of the microscopic organi-
sation and structure of tissues by computer-assisted 
analysis of images formed by microscopy.
Hydroxyapatite-calciumphosphate 
The principal inorganic constituent of bone.
Implant  
Medical device made from biomaterials, intended 
to use for repairing or replacing part of the body.
Osseointegration 
Contact established between normal and remodel-
led bone and an implant surface without the inter-
position of non-bone or connective tissue, at the 
light microscopic level.
Osteolysis 
Any focal area of bone loss adjacent to a prosthesis 
caused by the biological response to wear debris.
Press-fit 
Insertion of an implant into an undersized pre- 
made space.
Uncemented 
Implant designed for fixation by bone ingrowth.
Unipolar 
Prosthesis used for hemiarthroplasties with no across 
the joint articulating component. A unipolar device 
can be of monoblock or modular design.
Focal Knee Resurfacing with Metal Implants
13
1.1 BACKGROUND
1.1.1 Articular cartilage
The most common form of cartilage is hyali-
ne (Greek: mirror like) or articular cartilage (AC) 
that in the adult is found in most synovial joints 
(Fig. 1)1,2. AC is a solid but flexible specialised con-
nective tissue capable of enduring heavy loads over 
numerous and varying cycles throughout decades 
or even a lifetime. For instance the hip joint is lo-
aded with approximately 250% of the body weight 
at normal walking speed3. On average, an adult 
walks 305 km per year, which corresponds to about 
halfway around the Earth during a lifetime4. AC has 
the appearance of a smooth, translucent and pearly 
bluish tissue, with a thickness that varies between 
species and different joints5. In humans AC is 2-4 
mm thick6. The main function of AC is to provide 
a bearing surface that enables an almost frictionless 
movement between two opposing skeletal ends. 
Another function is to distribute transmitted loads 
towards the underlying bone during static loading 
as well as acting as a shock absorber under dynamic 
compression7,8. Also, fundamental for the protection 
against overload are the neuromuscular reflexes, the 
absence of which would be devastating for the joint 
as a consequence of stresses, strains and pressures of 
daily living9. The joint or articulation is a functio-
nal and structural unit situated at the point where 
two bones join for the purpose of body movement. 
Beside the two abutting bone ends the joint com-
prises of cartilage, capsule, ligaments and muscles 
(Fig. 2). The joint capsule has an inner layer, or sy-
novial membrane, rich with blood and lymphatic 
vessels that serves as a diffusion membrane produ-
cing synovial fluid. The synovial fluid acts as a lubri-
cation fluid further enhancing motion within the 
joint and serves as the only source of nutrition to 
the articular cartilage10.
1 INTRODUCTION
Figure 1.  Normal articular cartilage in a human knee.  Note 
the crescent-shaped fibrocartilaginous meniscus. Courtesy of 
Dr. Rikard Bessblad.
Figure 2.  The joint – a functional unit designed for movement.
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1.1.2 Histology
Cartilage tissue is composed of sparse chondrocy-
tes entrapped in abundant extracellular matrix. In 
contrast to other connective tissues the cartilage is 
avascular, alymphatic and aneural, thereby descri-
bed as an “isolated tissue deprived of communica-
tion with the vascular system”11,12. The physiological 
consequences of this are the lack of inflammation 
and pain in response to injury13. When observing 
AC with light microscopy (LM) it can be divided 
(for descriptive purpose) into three non-mineralised 
zones and one mineralised or calcified zone. The ti-
demark is seen as a wavy line that delineates where 
the non-calcified zone mineralises into the calcified 
zone. The superficial zone is thin, relatively cell rich 
with the collagen fibres oriented parallel to the arti-
cular surface. The intermediate zone is thick and the 
cells are less abundant than in the superficial zone, 
and here the fibres are oriented somewhat random-
ly in arcs. In the deep zone the cells and fibres are 
oriented perpendicular to the subchondral bone 
(Fig. 3)1.This structural organisation is probably de-
termined by the collagen fibres reflecting the tensile 
and compressive forces acting upon them (Fig. 4)14. 
The calcified zone enhances mechanical transition 
towards the underlying bone augmenting bioche-
mical fixation and mechanical attachment between 
cartilage and bone15. This structural organisation of 
AC creates a stiffness gradient facilitating distribu-
tion of loads from the softer articular surface to the 
stiff cortical bone14.
Articular 
Surface
Superﬁcial
Zone
Middle Zone
Deep Zone
Calciﬁed Zone
Subchondral 
boneTidemark
Articular 
Surface
Superﬁcial
Zone
Middle Zone
Deep Zone
Calciﬁed Zone
Subchondral 
boneTidemark Tidemark
Figure 3.  A schematic cross-section illustration of articular cartilage (AC).
Figure 4.  The architectural organisation of AC as a function of the loads acting on synovial joints.
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Figure 6.  Molecular ultrastructure of articular cartilage.
1.1.3 Biochemistry of cartilage matrix 
The matrix of the AC resembles a hyperhydrated gel 
composed mostly of water (65-80%) and a smaller 
proportion of solid mass. The matrix constituents 
are comprised mainly of collagens, proteoglycans 
(PG) and non-collagenous proteins (Fig. 5). The 
most abundant protein is the fibrillar type II colla-
gen that enmeshes large aggregating hyalorunic pro-
teoglycans. The PG´s are the second largest group of 
macromolecules in the AC composed by up to 100 
aggrecans attached to a single hyaluronic strand via 
link proteins. The aggrecan consists of a core protein 
to which glycosaminoglycans (GAG) chains are at-
tached. These chains are composed of 30-100 kera-
tan sulfates and chondroitin sulfates that are repulsed 
from each other by their negative charges (Fig. 6). This 
high density in negative charges attracts massive vo-
lumes of water producing a swelling of the matrix 
that is only counteracted by the tensile properties 
of the collagen fibres14. This complex interaction is 
what enables the AC matrix to withstand the com-
pressive forces acting on it while providing resilience 
and the capacity to recover shape when deformed16. 
The remaining AC constituents are smaller amounts 
of other components such as non-aggregating PG, 
non-collagenous proteins, minor collagens, lipids 
and minerals. Some of these plays a role in the inte-
raction with collagens, fibrillogenesis and interfibril-
lar communication, while the function of the others 
are not completely understood7. 
Cell
Collagen
GAG
Water
Mobile Ions
Water
Solid Mass
Collagens type II
Proteoglycans
Non-collagenous proteins
Chondrocytes
Ohters
Figure 5.  Distribution of water and solids (left) and main components (right) of AC. 
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Figure 7.  Cartilage metabolism directed by forces acting on the tissue.
1.1.4 Cartilage metabolism
The chondrocyte within the matrix is a metabolical-
ly active cell albeit the inert appearance of cartilage 
tissue11. AC turnover is a function of the synthesis 
of matrix molecules that are lost through degenera-
tion or injury. Unfortunately the healing power of 
AC is remarkably ineffectual considering the harsh 
biomechanical environment acting upon it13. Need-
less to say, the most limiting factor in this meagre 
healing process is the intrinsic avascular nature of 
AC. The necessary nutrients for restorative endea-
vour must therefore reach the chondrocyte by dif-
fusion from the synovial fluid. As the chondrocyte 
is entrapped in the pericellular matrix, it is unable 
to migrate and therefore the nutrient must traverse 
the matrix to reach the chondrocyte17. The passage 
of nutrients to the cells is restrained by size, charge 
and configuration of the matrix leaving an estima-
ted pore size of 6 nm7,18. Pressure loads acting upon 
the AC creates mechanical, electrical and chemical 
signals that helps the chondrocyte direct the synthe-
sis of the matrix (Fig. 7)19. With ageing, the matrix 
composition changes and the chondrocytes lose the 
ability to respond to these stimuli20.
CollaŐen ﬁbrilƐ
,oǁ cartilaŐe acƚƐ aƐ a ƐhocŬ abƐorber
WroƚeoŐlǇcan
Water
Water
Load-induced
compression
(reversible)
Core 
Protein
'lǇcoƐaŵinoŐlǇcan
ŐaŐ chainƐ Ͳ  
ﬁǆed neŐatiǀe charŐeƐ
Core 
Protein
How cartilage acts as a shock absorber
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Figure 8.  Cartilage degeneration and loss of macromolecules as a portend to OA.
1.1.5 Cartilage injury and repair
AC endures incredibly high mechanical stresses such 
as those caused by gravity and muscle contraction. 
It has been stipulated that human articular cartilage 
resists impacts in the range of 25 N/mm2 (2.5 kg/
mm2) without apparent damage21. When impacts to 
the articular surface exceed the AC capacity to ab-
sorb the load (by deformation, dampening and dist-
ribution of fluids) it eventually ruptures. Typically, 
like in the situation of degenerative joint diseases, 
changes in matrix composition, loss of molecules 
and metabolic imbalance between degradation and 
synthesis precede any visual sign of injury (Fig. 8). 
This process, when it develops, appears to be dri-
ven by a nucleus of chondrocytes in the affected 
area that starts to express an alternative part of the 
genome and produce matrix degrading enzymes, 
collagenases and metallo-proteases22. These enzymes 
also leach out into the joint fluid affecting parts of 
the joint distant from the original injury. The abili-
ty of the chondrocytes to maintain the extracellular 
matrix depends on their capability to detect changes 
in matrix composition and to respond by synthesis 
and assembly of the components necessary for the 
restoration23. The success rate of this healing process 
is correlated to the size of the lesion and the age of 
the individual20,24. The newly formed AC is unfor-
tunately often fibrocartilaginous in nature and ra-
rely replicates the elaborate structure of the original 
macromolecular network. The biomechanical conse-
quence is augmented permeability hence increased 
vulnerability to repeated trauma, which probably is 
responsible for the long-term deterioration and OA 
as an end result25. As early as 1743, Hunter observed 
that cartilage ‘(…) once destroyed it is not repaired’ 
26. This principle has not changed since.
1.1.6	 Prevalence	and	classification	of	cartilage	lesions
The aetiology and natural history of AC injuries are 
not completely understood. Also, the difficulty in 
diagnosing these injuries makes it problematic to 
establish their relationship to the development of 
OA. Acute or repetitive trauma can cause mechani-
cal disruption such as fissures, tears and focal carti-
lage defects27. Sports injuries as well as an increased 
activity level in an aging population have put this 
pathology on the rise. AC lesions can be divided in 
partial and full thickness injuries depending on the 
depth of the cartilage injury. Contained, or focal AC 
lesions can further be classified arthroscopically ac-
cording to Outerbridge or the International Cartila-
ge Research Society (ICRS) score (Fig. 9)28. Briefly, 
grades 1-2 are superficial lesions and generally do 
not require surgical treatment. Grades 3-4 are deep 
fissures or exposed bone respectively and thereby po-
tential candidates for surgical repair (Fig. 10). 
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Figure 9.  ICRS cartilage injury classification. Reprinted with permission from ICRS.
 
 
ICRS Grade 0 - Normal 
 
 
ICRS Grade 1 – Nearly Normal 
Superficial lesions. Soft indentation (A) and/or superficial fissures and cracks (B) 
 
    
A                     B 
 
ICRS Grade 2 – Abnormal 
Lesions extending down to <50% of cartilage depth 
 
 
 
ICRS Grade 3 – Severely Abnormal 
Cartilage defects extending down >50% of cartilage depth (A) as well as down to calcified layer (B) and down to 
but not through the subchondral bone (C). Blisters are included in this Grade (D) 
 
            A                     B                     C                        D 
 
ICRS Grade 4 – Severely Abnormal 
 
     
A                      B 
Copyright © ICRS 
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Table 1.  Characteristics of lesions encountered in arthroscopies performed for any reason.
Figure 10.  A full depth cartilage lesion in a femoral condyle. 
Courtesy of Dr. Leif Ryd.
Cartilage repair surgery is most suitable for patients 
younger than 40 and up to 50 years with a single 
focal lesion grade 3-4 of an area of 1 cm2 or more29. 
The few existing epidemiological studies on cartila-
ge injuries provide data on the incidence of carti-
lage lesions, indicating the approximate number of 
candidates for cartilage repair29-32. In these studies 
based on 1,000-31,000 arthroscopies the preva-
lence of chondral lesions of any type was reported 
to be about 60% of all arthroscopies performed 
for any reason. The most common reason for the 
arthroscopy was trauma (58-61%). Associated in-
juries such as meniscal tear or ligament injury were 
present in about 60-70% of all cartilage lesions. 
Totally 20-30% of all cartilage lesions were single 
focal lesions, the remaining were multiple lesions. 
The medial femoral condyle was the most frequent 
localisation (34-58%), and the second most frequ-
ent localisation was the patella-trochlear region. The 
size of the focal chondral lesions ranged from 0.5-1 
cm2 in about 25% of the cases, between 1-2 cm2 in 
29-42% of the cases, and lesions larger than 2 cm2 
were reported in 7-12% of the cases. The most com-
mon type of lesion was partial thickness grade 1-2 
found in approximately 40-65% of the cases. Grade 
3-4 accounted for 36-60% of the lesions (Table 1).
In summary, focal cartilage lesions grade 3-4 with 
an area of at least 1 cm2 in patients under the age of 
40 years and up to the age of 50 years accounted for 
5-7% and 9-13% of all arthroscopies respectively. 
As aforementioned these lesions left untreated do 
not heal or only partially heal, and even after various 
kind of treatment they might progress to OA. Hen-
ce, it is generally accepted that these lesions portend 
to the origination of OA.
 
Table 1 -  Summary of cartilage lesions at arthroscopy
Frequency Cartilage lesions were found in approximately 60% of all arthroscopies.
Indication for arthroscopy The cause of arthroscopy was trauma in about 60%.
Associated injuries These were found in about 60% of the cases.
Type of lesion Focal lesions accounted for approximately 30% of the cartilage lesions.
Localisation The most frequent localisation was the medial femoral condyle.
Size of the lesion The most frequent size was an area of about 1-2 cm2 (30%).
Classification Superficial lesions accounted for 50% of the cases.
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1.1.7 Biological treatment 
A better understanding of the limitations in the 
natural repair process has contributed to the inte-
rest during the last three decades in the repair and 
regeneration of articular cartilage tissue. There is 
scientific evidence that transplanted chondrocytes, 
perichondrium, periosteum, growth factors and ar-
tificial matrices can stimulate neoformation of car-
tilaginous tissue27.
1.1.7.1 Abrasion chondroplasty, Pridie drilling 
and microfracturing 
Abrasion chondroplasty, Pridie drilling and mi-
crofracturing are three methods which all disrupt the 
subchondral bone plate (Fig. 11), permitting a hea-
ling process stimulated by the vascular system13,33-35. 
The cartilage defect is filled with a reparative tissue 
that undergoes a maturation process to reconsti-
tute a hyaline-like fibrocartilaginous tissue36. This 
reparative tissue is composed of larger proportions 
of type I collagen and less PG than normal hyali-
ne cartilage36. The success rate of this healing tissue 
is highly variable depending on the severity of the 
lesion, age of the patient, physical activity and fol-
low-up time32. These techniques have been advoca-
ted mainly for patients younger than 40 years and 
with rather small lesions37.
1.1.7.2 Osteochondral autografting and  
allografting 
Autologous mosaicplasty is more commonly used 
than allogeneic techniques. It implicates resurfa-
cing a defect with multiple osteochondral plugs 
(Fig. 12)38,39. The main drawback is donor site mor-
bidity since the plugs are surgically removed from 
an already diseased joint, and given their size it is 
unlikely that the donor site will heal8. The viability 
of the plugs, particularly at the border, is possibly 
impaired and further jeopardised by the hammering 
process to press-fit them into the defect40,41. Once in 
place the plugs resemble a cobblestone surface with 
questionable nutritional capacity to mutually adhe-
re and with a considerable height mismatch relative 
to surrounding and opposing cartilage surfaces42. 
Allographic osteochondral plugs are similar to auto-
logous plugs but are intended to act as a mechanical 
substitution of the defect as these do not stimulate 
a cartilage repair response. These can be used to re-
store bone stock in complex salvage procedures43,44. 
This method has performed well in clinical settings 
even at long-term follow-up but might have the 
drawback of immunological reaction that in vivo is 
less extensive when compared to experimental set-
tings45,46. Another disadvantage of a more generali-
sed implementation of this technique is the shortage 
and storage inconvenience of the cryopreserved os-
teochondral plugs.
1.1.7.3 Autologous chondrocyte implantation  
In autologous chondrocyte implantation (ACI), 
healthy cartilage is obtained arthroscopically and 
subsequently enzymatically digested to release 
chondrocytes, which are expanded in culture for 
about 11-21 days. This will generate approximately 
a 10-fold increase in the number of cells obtained 
Figure 11.  A focal cartilage lesion treated with perforation 
of the subchondral bone plate; microfracturing. 
Figure 12.  Mosaicplasty of a chondral lesion. Note donor 
site morbidity.
Focal Knee Resurfacing with Metal Implants
21
Figure 13.  A schematic illustration of the harvesting and implantation of autologous chondrocytes.
11
from the biopsy. A suspension with about 2.5-5 mil-
lion cells is then transplanted directly into the de-
fect beneath the coverage of a sutured-periosteal flap 
(Fig. 13)46,48. A matrix-associated variant (MACI) 
was introduced to ACI, where the chondrocytes 
are embedded in a gel-like matrix rather than a sus-
pension and thereby avoid the need for periosteal 
flaps49. More recently these methods have been refi-
ned by the selection of a subgroup of chondrocytes 
from the harvested cell (characterised), which has a 
high chondrogenic capacity, so-called characterised 
chondrocyte implantation (CCI)50.
In a Cochrane review from 2011 six heterogeneous 
randomised trials compared ACI to autologous mo-
saicplasty (three trials) and to microfracture (three 
trials). The authors concluded that there was insuf-
ficient scientific evidence to state whether ACI is 
superior to the other cartilage repair interventions51. 
Nevertheless there is some evidence from a well-per-
formed RCT that CCI combined with MACI per-
forms better than microfracture at two-year fol-
low-up in terms of pain and function52.
1.1.7.4 Tissue engineering strategies
With the three key constituents cells, matrix scaf-
fold and signalling molecules, tissue-engineering 
researchers aim to regenerate functional and en-
during cartilage tissue53,54. Most of the research so 
far has been conducted in a laboratory setting, alt-
hough some work with animals and humans has 
been conducted. Bone marrow-derived mesenchymal 
stem cells (MSCs) can differentiate to chondrocytes 
in the presence of stimulation factors or signalling 
molecules such as growth factors16. A cell carrier or 
matrix (scaffold) enhances the process of cartilage 
tissue growth by force of its peculiar geometrical 
configuration, stimulating cell attachment and bin-
ding of growth factors55. Signalling molecules spe-
cifically guide the course of differentiation in the 
desired (chondrogenic) direction56. These building 
blocks can be assembled and fully differentiated in 
vitro and the final implant can then be transplanted 
to the defect. The drawback is the difficulty to fix-
ate and fit the implant to the natural curve of the 
condyle. The basic building blocks (matrix, cells 
and signalling molecules) can be produced in vitro 
and thereafter assembled and differentiated in vivo 
(in the cartilage defect). This will more likely adhe-
re and follow the natural curve of the condyle but 
will differentiate less accurately to the desired tissue. 
At last, growth factors (no cells) in a matrix can be 
applied in situ to a defect stimulating migration and 
proliferation of MSCs57.
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1.1.8 Focal knee resurfacing with metal implants 
Biological treatment methods are less effective with 
increasing patient age and they all claim a ma-
turation process of 12-14 months58. Primary joint 
replacement is not ofthen indicated for the midd-
le-aged patients with cartilage lesions. Moreover, 
joint replacement in the middle-aged patient with 
early OA has shown inferior results with increased 
risk for revision surgery and high morbidity59. The-
refore there is a treatment gap for the middle-aged 
patients with symptomatic full depth focal cartilage 
lesions59,60. An attractive alternative treatment stra-
tegy is to resurface the cartilage defect with a metal 
implant (FKRM). When we started this project in 
2007 we were aware of only two other groups in the 
world investigating this concept61,62. FKRM can be 
regarded as the final attempt at joint preservation, 
and consequently the salvage procedure for a failed 
resurfacing implant is a joint replacement. A provi-
sional treatment with FKRM will hopefully delay 
or indefinitely postpone the need for arthroplasty. 
There are three clinical trials (level of evidence IV) 
performed where cartilage defects are resurfaced 
with metal implants showing promising results in 
terms of improved pain and function63-65. A wor-
risome revision rate of 28% has been reported that 
was primarily caused by progression to OA indica-
ting that FKRM does not halt OA development in 
all cases66. Hence, caution is warranted when selec-
ting patients for this treatment, moreover patients 
should be properly informed on the possible tempo-
rary effect of this procedure64. Finally, resurfacing a 
full thickness focal cartilage lesion in the knee with 
a metallic implant articulating against the opposing 
tibial cartilage (unipolar) requires three fundamen-
tals to succeed. First, the implant must bond to the 
host bone. Second, the surrounding cartilage should 
not be damaged but rather adhere to the implant. 
Third, it is imperative that the opposing cartilage 
withstands the new biomaterial over time (Fig. 14).
Three challenging issues
Figure 14.  A schematic illustration showing the three major challenges when treating full depth focal cartilage defects with 
metal implants.
Implant must not damage
opposing cartilage
Implant must 
bond to bone
KppoƐinŐ cartilaŐe
Bone
ImplantAdũacenƚ 
cartilaŐe
Surrounding cartilage
should accept, and
preferably seal to
the implant
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1. Develop a new treatment concept including an implant and instrumentation 
device for the treatment of femoral condylar full depth focal cartilage lesions.
2. Bridge the gap from technological development to clinical application by asses-
sing the biological safety of the implant using a sheep animal model.
3. Provide scientific data for the decision to enter clinical trials using FKRM im-
plants with the aim to reduce pain and restore function in an active middle-aged 
patient group with symptomatic deep focal femoral condylar lesions, this rema-
ins a clinical challenge.
1. Osseointegration is obtained for an uncemented press-fit implant with a double 
coated Ti and HA layer on a  Co – Cr  implant that is immediately loaded post-
operatively.
2. Cartilage remains healthy adjacent to the implant while full depth untreated 
cartilage defects do not heal.
3. Cartilage damage of the surface opposing a metal implant of optimal fit and ideal 
position is acceptable.
4. Joint cartilage homeostasis is not disturbed in knees treated with a metal implant.
2  GENERAL AIMS 
3  HYPOTHESES
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4.1 IMPLANT
A medical and technological interdisciplinary team 
was created to develop a new treatment concept for 
sealing focal cartilage defects with metal implants 
(Fig. 15). The introduced (first generation) implant 
(Fig. 16) was designed as a spherical monobloc im-
plant of functional gradient material (FGM). FGM 
is characterised by the combination of different ma-
terials with a gradient across different levels. Spe-
cifically, the articulating superficial layer was made 
of pure stainless steel (316L) that was gradually re-
placed with bioactive hydroxyapatite (HA) towards 
the bone. Because HA is brittle, a blend of 50% 
HA and 50% stainless steel achieved mechanical 
stability although remaining osteoconductive. This 
characteristic allows the implant to benefit from a 
specific feature of each material according to its par-
ticular purpose. The first FGM implant was manu-
ally manufactured using the Spark Plasma Sintering 
(SPS) technique characterised by sintering of the 
metal powder by high pressure in combination with 
direct electrical current at high voltage. The outer 
diameter of the implant was 10 mm and the peg 
measured 10 mm in length and 2 mm in diameter. 
The radius of the curvature was 17 mm in all planes. 
The articulating surface of the implant was manual-
ly polished to a roughness (Ra) < 0.03 (Fig. 16). The 
first generation FGM implant was successful from 
a fixation point of view according to pull-out tests 
(unpublished results) performed at the Royal Insti-
tute of Technology, Stockholm (KTH). However, 
the FGM implant development was not practical 
from a manufacturing point of view as they were 
4   IMPLANT, ANIMALS AND METHODS 
Figure 15. A medical-technological interdisciplinary team consisting of engineers, scientists and staff from Episurf Medical AB. 
Figure 16.  Pictures showing the first generation (left) and second generation (right) Episealer ® implant. Courtesy Episurf 
Medial AB, Stockholm.
First generation Episealer ® implant
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Figure 17.  Immersion test performed at KTH showing galvanic corrosion of the implant (to the left).
manually produced and polished. Additionally, the 
SPS machine is only available for research-scale 
productions. Hence it was decided to abandon the 
FGM material in favour of time-honoured cobalt – 
chrome (Cr – Co) alloy. 
After completing the first part of our pilot study we 
observed some yellow secretion on the deeper part 
of the firts generation implant. Analyses performed 
at KTH (unpublished results) showed galvanic cor-
rosion, which occurs when two different metals are 
combined in a corrosive electrolyte (Fig. 17).
The second-generation implant was designed as a 
double-curved monobloc Cr – Co implant. The mo-
nobloc core was plasma sprayed with a double-coa-
ting of titanium (Ti) and HA for long-term fixation 
purposes. First we used a layer of commercially pure 
titanium (60 um) onto which a second layer of HA 
(60 um) was plasma sprayed (Plasma Biotal Ltd., 
Buxton, GBR). These implants were manufactured 
with a computer-aided design and manufacturing 
(CAD/CAM) technique modelled from one “stan-
dard” sheep knee as captured from CT DICOM-fi-
les. The second generation FKR implant had radii 
of 12 and 19 mm that followed the sagittal and 
transversal condylar curvature (respectively) of the 
standard sheep. The hat of the implant had a diame-
ter of 7.5 mm. For primary fixation the implant had 
a peg that measured 10 mm in length and 2.0 mm 
in diameter, intended to be press-fit into an under-
sized drill hole of 1.8 mm (Fig. 16).
4.1.1 Titanium and hydroxyapatite coating
A prerequisite for the long-term success of ortho-
paedic and dental implants is the permanent fixa-
tion to the bone without intervening soft-tissue, so 
called osseointegration, which was first described by 
Brånemark67. Prosthesis and implants can be im-
planted into the body either with cement using po-
lymethylmethacrylate (PMMA) or without PMMA 
(cementless fixation). We used the latter since it has 
been suggested that PMMA is not suitable for fix-
ation in young patients (< 50 years) who require a 
more stable fixation where bone ingrowth is desi-
rable. Drawbacks with PMMA such as cell necro-
sis, endosteal bone resorption and cement failure 
have been reported68. HA or calcium phosphate 
(Ca10(PO4)6(OH)2) is a bone mineral and constitu-
tes 50% of the human bone volume and this mo-
lecule can be synthetized artificially. HA has an os-
teoconductive property that enhances the bonding 
of bone (osseointegration) and is therefore widely 
used in grafts for bone repair or coatings on metal 
implants (Fig. 18)69,70.
   However, HA might resorb or degrade in biolo-
gical settings and subsequent disintegration could 
compromise implant fixation71. Chemical com-
position, mechanical characteristics, crystallinity, 
porosity, thickness and roughness as well as the 
material and texture of the implant will influence 
HA´s performance in terms of osseointegration. It 
is recommended to have as high calcium phospha-
te purity as possible (95-97%) with a Ca/P ratio of 
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1.76. We followed international standards; HA pu-
rity was in the order of 95%, Ca/P ratio was 1.67 
and cristallinity 60% (ASTM 88).  High crystallini-
ty with low porosity is mechanically stable but less 
bioactive (less osteoconductive) and might induce 
delamination of larger HA fragments that cannot 
be dissolved by phagocytosis. This could locally de-
crease pH further stimulating HA dissolution or 
hypothetically migrate to the joint, and potentially 
act as third-body wear particles. A thicker coating 
larger than 100 μm might also be predisposed to 
mechanical fatigue stress, therefore a 50 μm thick 
coatings has been recommended72. Also, high surfa-
ce roughness increases contact with body fluid en-
hancing bioactivity through dissolution and apatite 
precipitation. Finally, the choice of implant material 
and texture is of outmost importance for osseoin-
tegration. The most common biomaterials used in 
orthopaedics are Co – Cr or Ti alloys as they are 
biocompatible with favourable corrosion proper-
ties and fatigue strength. Both are stiffer than bone 
but Ti alloys produce less stress shielding and have 
a higher bonding strength compared to HA73. The 
surface of the metal used for uncemented fixation 
can be treated either by grit-blasting or beading to 
promote osseointegration. A porous coating can in-
duce osseointegration per se and is therefore more 
effective than grit-blasting. Nevertheless, it has been 
shown that a porous coating alone without HA can 
induce a fibrous fixation rather than bone ingrowth 
especially if gaps and micro-motion are present at 
the implant-bone interface74. HA limits the forma-
tion and stimulates the conversion of fibrous tissue 
to bone even in the presence of gaps up to 1 mm, 
both in unloading and loading conditions75-77. This 
circumferential bone apposition (sealing effect) pre-
vents polyethylene, metal debris or other fluids to 
penetrate along the bone-implant interface78,79.
Figure 18.  A scanning electron microscopy picture showing the Episealer® HA layer (left) at higher magnification (right).
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4.2 ANIMAL MODELS 
Translational research bridges basic science with 
clinical trials and often involves animal studies to 
evaluate the safety and efficacy of novel treatment 
methods as well as the optimisation of existing ones 
before application in humans. The common descent 
of all living organisms makes this strategy possible 
in combination with the conservation of metabolic 
and developmental pathways as parts of the evolu-
tionary principle. Studying model organisms can be 
informative, but care must be taken when extrapola-
ting from one organism to another80. For ethical re-
asons and to optimise the development of new treat-
ment possibilities, animal studies are critical in knee 
pathophysiology research81. Each animal model has 
its own advantages and draw-backs. The cartilage of 
small animals (mice, rats and rabbits) is very thin 
making these animals inferior for use in the study of 
surgical implants. Large animal models offer thick-
er cartilage but require more logistical, financial 
and ethical considerations. Dogs are well suited for 
specific rehabilitation protocols such as treadmills 
but exhibit thin cartilage and require more ethical 
considerations due to their status as companion 
animals. Pigs are similar to humans with respect to 
weight-bearing conditions and cartilage thickness 
but their large size and aggressiveness makes them 
difficult to handle in research facilities. Within the 
horseracing industry, much research has been done 
on cartilage lesions82. While cartilage defects with a 
similar volume as in humans can be obtained, the 
loading condition of the stifle joint will however ex-
pose the knee to loads greater than in humans.
4.2.1 Sheep
Sheep (Ovis aries) are quadrupedal mammals com-
monly kept as livestock. They re-chew plant matter 
to stimulate digestion, a process called rumination. 
The height and weight of sheep depends on the 
breed. Ewes (adult female sheep) typically weigh 45-
100 kg and rams (adult male sheep) 45-160 kg. They 
generally live for 10-12 years, although some sheep 
live as long as 20 years (Fig. 19). Sheep and goats 
are commonly used models when studying chondral 
repair of partial and full thickness cartilage lesions. 
They have the advantage of being large animals with 
a similar knee anatomy to humans. In addition, the 
biomechanics are comparable to humans regarding 
weight-bearing, joint size and cartilage thickness 
(0.5-1.5 mm). Also, they have limited intrinsic hea-
ling capacity (a critical size defect is approximately 
6 mm). The caprine model allows surgically crea-
ted defects with a diameter of 4-15 mm, but not 
larger-sized lesions that are considered relevant for 
humans. Goats have a thicker cartilage layer, but on 
the other hand they may develop OA by the age 
of 2 years61,83,84, which might jeopardise the evalu-
ation of treatment effects. Finally, another benefit 
of using sheep is that there are well-established pro-
tocols for anaesthesia and analgesia. Together with 
simple housing conditions, they make well-powered 
studies possible85. We chose Swedish landrace ewes 
between 2-6 years (skeletally mature “middle-age” 
animals) for the experiments in our studies. 
Figure 19.  A sheep, operated unilaterally with a FKRM im-
plant in the right stifle joint (note bandage).
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4.2.2 Ethics
In 1822, the British Parliament enacted the first law 
for animal protection preventing cruelty to cattle 
(British Animal Protection Legislation), being the 
oldest known debate on ethics when using animals 
in research. In Sweden, a local ethics committee, 
which serves directly under The Swedish Board 
of Agriculture, upholds guidelines and standards 
for research which intends to use animals. Resear-
ch must prove the potential for benefit to human 
health, the minimisation of pain and distress, and 
timely and humane euthanasia. In addition, expe-
rimenters must justify their protocols based on the 
principles of Replacement, Reduction and Refine-
ment86. Replacement refers to efforts to engage al-
ternative methods to animal use. For instance, this 
could include the use of computer models, non-li-
ving tissues and cells, and when animal models can-
not be avoided, replacement of “higher-order” ani-
mals (primates and mammals) with “lower” order 
animals (e.g. cold-blooded animals, invertebrates, 
bacteria). Reduction refers to efforts to minimi-
se the number of animals used in an experiment, 
as well as prevention of unnecessary replication of 
previous experiments. Finally, refinement refers to 
efforts to make experimental designs as painless and 
efficient as possible. We obtained ethical commit-
tee approval by Uppsala Djurförsöksetiska Nämnd 
(Uppsala Animal Experiments Ethical Board,
Dnr. C271/8 and C135/10).
 
4.2.3 Summary of all animals 
Thirty-seven female sheep were used in this thesis. 
The animals were operated with an implant in the 
weight-bearing surface of the medial femoral con-
dyle in one or both knees. In the pilot study they 
were operated bilaterally with implants. In the last 
study (Paper IV) they were operated bilaterally, 
with an implant in one knee and with an iatroge-
nic full-depth lesion as a control defect in the other 
knee. The remaining sheep (Paper II-III) were ope-
rated unilaterally using the contralateral knee as a 
control. The first 28 sheep came from one breeder 
and the remaining nine sheep came from two other 
breeders. The age of the sheep ranged from 2-7 years 
and weighed in the range of 60-99 kg. All animals 
were housed at the department of Clinical Science, 
Swedish University of Agriculture Sciences (SLU) in 
Uppsala, Sweden. They were kept indoors in stables 
in groups of three, and for the long-term studies 
(Paper II-IV) they were kept in an outdoor grass 
paddock with a windbreak after the first two weeks. 
Food was given twice a day and water was freely av-
ailable. The animals were well acquainted with the 
persons handling them and they were observed da-
ily to monitor their general condition, signs of pain 
and lameness (Fig. 20).
Paper I 
12 ewes
Paper III 
16 ewes
Paper IV 
9 ewes
Paper II
Subgroup of 9 ewes 
from Paper III
Total 37 ewes 
where used in 
the thesis
Figure 20.  Summary of all animals used in this thesis.
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4.2.3.1 Paper I (pilot study)
Twelve healthy Swedish landrace ewes from the same 
breeder were operated bilaterally with an implant 
between March and December 2009. The mean age 
and weight of the sheep were 5 years (range 5-7) and 
82.5 kg (range 70-99). The animals were operated 
in two different time periods. The first batch of six 
animals, batch 1, were operated bilaterally with first 
generation implants in March 2009 and euthanized 
in April and June 2009 respectively. Three of them 
were euthanized six weeks after surgery and three 
were euthanized at three months after surgery. The 
second batch of six sheep, batch 2, were operated 
bilaterally with second generation implants in De-
cember 2009. One died immediately postoperative-
ly, thus five sheep were euthanized six weeks after 
surgery in January 2010. 
 In summary, a total of eleven sheep operated bi-
laterally (22 implants) were included in the analy-
sis. Of these, eight animals were sacrificed six weeks 
after surgery (16 implants) and three animals were 
sacrificed three month after surgery (six implants). 
These animals were pooled together as one group 
and presented in Paper I (Fig. 21).
4.2.3.2 Paper II-III (preclinical studies)
Sixteen healthy Swedish landrace ewes from the 
same breeder were operated unilaterally with a se-
cond-generation implant using the opposite knee 
as the control knee, between June and December 
2010. The mean age and weight of the sheep were 
4 years (range 2-6) and 82.5 kg (range 70-99), re-
spectively. These animals were also operated in two 
different time periods. The first batch of ten animals 
was operated in June 2010. One died two months 
postoperatively. From the first batch three animals 
were sacrificed six months after surgery, and the re-
maining six animals were euthanized one year after 
surgery. The second batch of six animals was opera-
ted in December 2010. From the second batch, two 
animals died and the remaining four were euthani-
zed six months after surgery.
 In summary, 16 ewes were used for Paper III, out 
of which three died. One died immediately post-
operatively and two were sacrificed at two months 
due to pneumonia and septic arthritis respectively. 
Thus, thirteen sheep operated unilaterally using the 
contralateral side as a control were used in the analy-
sis. Of these thirteen animals, seven were sacrificed 
six months postoperatively and six animals were sa-
crificed one year postoperatively. The animals were 
pooled together as one group and presented in the 
analysis of Paper III (Fig. 22).
 A subgroup of nine animals from Paper III 
(batch 1) was used in Paper II (Fig. 23).
4.2.3.3 Paper IV (comparative study)
In Paper IV, nine healthy Swedish landrace ewes 
from two different breeders were operated bilater-
ally with an implant in one knee and with an iatro-
genically produced full-depth lesion (the size of the 
implant, 7.5 mm) as a defect control in the other 
knee. Special care was taken not to penetrate the 
subchondral bone when producing the full-depth 
focal lesion. The nine animals were operated in 
April 2011. One of the nine ewes died immediately 
postoperatively and two others were sacrificed two 
months after surgery due to pneumonia and severe 
limp, respectively. The remaining six animals were 
euthanized at six months and used for the analysis 
of Paper IV (Fig. 24).
In addition to these six ewes, six matched ewes from 
Paper III were included for analysis of cartilage 
health adjacent to the implant (n = 12).
Figure 21.  Animals used in Paper I (n = implant).
Pilot study batch 1
&irsƚ generation 
implants
6 ewes
SacriĮced aŌer͗
- 6 weeks (n = 6)
- 12 weeks (n = 6)
Pilot study batch 2
Second generation 
implants
6 ewes
SacriĮced aŌer͗
- 6 weeks (n = 12)
One died 
post-
operatiǀelǇ
Pilot study
Paper I
11 ewes
(n = 22)
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Figure 23.  Animals used in Paper II (n = number of animals).
Figure 24.  Animals used in Paper IV (n = number of animals).
Paper III
13 ewes
Paper II
Kn osseoinƚegration
Subgroup of 9 ewes from 
Paper III
SacriĮced aŌer͗
- 6 months (n = 5)
- 12 months (n = 4)
One died 
post-
operatiǀelǇ
9 ewes
One was 
sacriĮced aƚ 
2 months due 
to lameness
One was 
sacriĮced aƚ 
2 months due 
to pneumonia
oŵparatiǀe sƚudǇ
Paper IV
6 implants
6 defects
6 ewes
SacriĮced aŌer͗
- 6 months (n = 6) 
Figure 22.  Animals used in Paper III (n = number of animals). 
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Figure 25.  Professor Anne-Sofi Lagerstedt providing anaesthesia to a sheep. 
4.3 METHODS
4.3.1 Anaesthesia in sheep
There are some anaesthesiological difficulties in 
sheep and other ruminants that are not encounte-
red in simple stomached animals that require special 
consideration. The rumen content may be regurgi-
tated during anaesthesia since it cannot be emptied 
by pre-operative starvation. Hence, precautions 
must be taken to ensure that rumen contents are not 
aspirated. Also, gas will build up in the rumen indu-
cing swelling that reduces lung capacity and impairs 
ventilation. Sheep salivate constantly during general 
anaesthesia; therefore endotracheal intubation with 
a cuffed tube is essential whenever general anaest-
hesia is induced in adult ruminants. Additionally 
a gastric tube should be placed to avoid distension 
and regurgitation. Risks of regurgitation, salivation, 
aspiration and ruminal distension are also present 
during recovery (Fig. 25). For anaesthesia protocol 
see Methods in Paper I-IV.
4.3.2 Surgery
All operations were carried out under aseptic condi-
tions by the same surgeons (HNS, NMC and LR). 
The medial femoral condyle was exposed through 
a medial parapatellar 5-6 cm incision through skin 
and subcutaneous tissue. After inspecting and evalu-
ating the general health of the knee according to the 
modified O´Driscoll score (Table 2) the operation 
was carried out using a set of specially designed in-
struments. First, a centralising aiming guide with a 
built-in guiding tube, adapted to the contour of the 
weight-bearing condylar surface was applied and 
fixed to the condyle by means of three pins engaging 
the metaphysis outside the articulating cartilage 
(Fig. 26). Through the guiding tube, sitting perpen-
dicular to all tangents of the articulating surface, a 
specially designed drill was used to cut the cartilage 
and the underlying bone in a way to exactly corres-
pond to the shape of the implant (Fig. 26).
According to the pilot study (Paper I), we aimed 
to position the implant 0.5 mm recessed below the 
surrounding cartilage (Paper II–IV). The depth of 
the implant level3 was incrementally increased by 
0.01 mm by turning the guide tower clock-wise one 
step until a satisfactory level was achieved (Fig. 27). 
A slightly smaller testing device with identical arti-
culating contour as the final implant was used ite-
ratively to control the position in height relative to 
the surrounding cartilage before finally inserting the 
implant (Fig. 27).
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Figure 26.  Individualised aiming tube (left) perpendicular to the condylar surface and cartilage cutting device (right). 
These pictures show instruments sized for human use, and shown on a human femoral model.
Figure 27.  The Epiguide® tower clock that regulates depth of iatrogenic cartilage defect (left), final implant position (right).  
These pictures show instruments sized for human use, and shown on a human femoral model.
Finally, the joint capsule was sutured in a continuous 
pattern using polydioxanone (PDS®, Ethicon) and 
the subcutaneous tissue and skin were closed in a 
similar pattern using polygliglecaprone 25 (Mono-
cryl®, Ethicon). No surgical complications occurred 
during the operations. The sheep were extubated in 
their stables and under continuous observation and 
regained consciousness within one-hour postoperative-
ly.
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4.3.3 Laser measurements
A total of 38 implants were laser-scanned and ana-
lysed for implant position in terms of height relati-
ve to surrounding cartilage. Eighteen of these were 
additionally analysed regarding tilting in relation to 
cartilage level. Five implants were lost for analysis 
due to technical problems related to either the ne-
gative print, scanning of the print or software used 
for analysis. In Paper I 20 implants were analysed 
in terms of height (out of 22 implants operated). 
In Paper III twelve implants were analysed for both 
height and tilting (out of 13 implants operated). 
Finally, in Paper IV 6 implants were analysed for 
height and tilt in 6 animals using the laser scanning 
method. The first step was to take a negative print of 
the medial femoral condyle (housing the implant) 
using an alginate plaster (Hydrogym; Zhermack, 
Badia Polesine, Italy) (Fig. 28). This negative print 
was subsequently analysed using a high precision (< 
1 µm) laser-scanning device (www.nikonmetrology.
com; LK, Scandinavia, Stockholm, Sweden). The 
contour of the femoral condyle including the im-
plant was digitised using a specific software program 
(Metris Focus Inspection 9.2) (Fig. 28).
 This software calculated the radius of the condyle 
curvature in both the sagittal and coronal planes 
using a set of data points from the surrounding car-
tilage (Paper I). In the remaining papers (III and 
IV) the radius of the condyle curvature was pre-set 
to the radius of the implant. The surface of the im-
plant was then marked with five different referen-
ce points (centre, anterior, posterior, medial and 
lateral). From these landmarks the implant height 
(mm) relative to the surrounding condylar radii at 
the cartilage surface plane was calculated (Fig. 29).
 Using the relative height (h) and the inter-dis-
tance (d) of the antero-posterior or medio-lateral 
data points, respectively, the angulation (tilt) of the 
implant relative to the surrounding condylar surfa-
ce was calculated by the appropriate trigonometric 
equation (Arctan (h/d)).
Figure 28.  The negative print in alginate plaster (left) and the digitised image (right).
Figure 29.  Postoperative laser measurements used to evaluate implant position (Courtesy of LK Skandinavia AB).
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4.3.4 Macroscopic cartilage and joint health
After euthanasia the animals were autopsied at the 
National Veterinary Medical Institute (SVA) accor-
ding to their general routine and analysed for gene-
ral diseases that could possibly influence the outco-
me. There was not sign of toxic reaction that could 
be caused by the implant material. The results were 
noted in autopsy protocols. The general joint health 
was evaluated according to a modified O´Driscoll 
score (0-6 points instead of 0-10 as the parameter 
restoration of contour and cartilage erosion of the 
graft was not possible to evaluate) (Table 2)87,88. As 
the joint had been opened a sample of joint fluid was 
taken. Both tibial and femoral condyles were disse-
cted and high-resolution photographs (Canon EOS 
450D, EF-S 17-55 mm f/2.8 IS USM lens fixated 
at a distance of 0.3 m, using 35 mm focal length) 
were taken to enable macroscopic evaluation accor-
ding to the ICRS score. Articular cartilage lesions 
were thus classified according to a scale 0-4, where 
grade 0 is normal, grade 1 is fibrillation (softening 
not possible to evaluate on photograph), grade 2 is 
superficial fissures (not reaching the subchondral 
bone), grade 3 fissures to the subchondral bone and 
grade 4 exposed subchondral bone28,89.
4.3.5 Histology
Histology is the microscopic study of cells and tiss-
ues. In order to be able to microscopically evaluate 
the tissue or sample it has to be prepared. Sample 
preparation consists of fixing, processing, embed-
ding, sectioning and staining. Fixing uses chemi-
cal fixatives to maintain the structure of cells and 
to preserve the tissue from degradation. The most 
commonly used fixative is 10% neutral buffered 
formalin. Processing consists of dehydration, cle-
aring and infiltration of tissues. The goal is to re-
place the water in the tissue with a substance that 
hardens (most commonly paraffin) permitting thin 
sections to be cut. To remove the water from the 
tissue, the samples are transferred between baths of 
progressively more concentrated ethanol (dehydra-
tion). Then the alcohol is removed from the tissue 
(clearing) using a hydrophobic agent such as xylene. 
Finally, the xylene is replaced with molten paraffin 
wax (infiltration). Embedding; samples are placed 
into moulds with the embedding material that har-
dens after cooling. These blocks are then ready for 
sectioning. Sectioning; a microtome is used to cut 
about 5 micrometre thick tissue samples for light 
microscopy. The most commonly used direction to 
cut the sample is perpendicular to its surface (cross 
section). Staining; this enhances the ability to visu-
alise or identify microscopic structures (since bio-
logical tissues have almost no contrast in the light 
microscope). There are many different types of sta-
ins, and among them safranin and toluidine blue 
are used to identify cartilage. These stains are ba-
sic or cationic dyes that bond to the strongly acidic 
Table 2 -  Joint health evaluation according to the modified O´Driscoll score
CONTRACTURE Score
None 2
Partial 1
Complete 0
ADHERENCE
None 2
Minimum 1
Large 0
GENERAL CARTILAGE APPEARANCE 
Translucent 2
Opaque 1
Discoloured 0
Table 2.  Classification used to evaluate general joint health intra-operatively and post mortem. 
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Table 3 - Histological evaluation according to Mankin 
Score
STRUCTURE Normal 0
Surface irregularities 1
Pannus and surface irregularities 2
Clefts to transitional zone 3
Clefts to radial zone
Clefts to calcified zone
4
5
Complete disorganisation 6
 CELLS Normal 0
Diffuse hypercellularity 1
Cloning 2
Hypocellularity 3
SAFRANIN STAINING Normal 0
Slight reduction 1
Moderate reduction 2
Severe reduction 3
No staining 4
TIDE MARK Intact 0
Crossed by blood vessels 1
(anionic) glycosaminoglycans staining the tissue red 
(metachromasia). This reaction between laboratory 
chemical and tissue is termed histochemistry and is 
frequently used in qualitative cartilage evaluation. 
Artefacts are features in the tissue that interfere with 
normal histological examination. These can be in-
troduced prior to the collection of the tissues or can 
result from tissue processing. Processing can lead to 
changes like shrinkage, colour changes and structure 
alterations in the tissue.
4.3.5.1 Cartilage evaluation of joint surfaces
In Paper I samples were prepared and evaluated as 
follows: the medial tibial surfaces were dissected 
and placed in 2% glutaraldehyde 1% paraformal-
dehyde in 0.1 M sodium cacodylate buffer, pH 7.4 
and refrigerated. Areas chosen to represent cartilage 
facing the implants were cut and rinsed in 0.1 M 
phosphate buffer, pH 7.4 post-fixed in 2% osmium 
tetroxide 0.1 M phosphate buffer, pH 7.4 at 4 °C for 
2 h, dehydrated in ethanol followed by acetone and 
embedded in LX-112 (Ladd, Burlington, Vermont, 
USA). Semi-thin sections were cut and stained with 
toluidine blue and used for light microscopic ana-
lysis. Digital images were taken by using a Morada 
camera (Olympus Soft Imaging Solutions, GmbH, 
Münster, Germany). Damage to the cartilages were 
evaluated according to a modified Mankin score 
(the smear layer and calcified zone is not evaluated); 
grade 0-12: where grade 0 is normal cartilage and 
grade 12 is totally deranged cartilage (Table 3)90,91. 
In Paper III-IV, samples were prepared similar to 
Paper I while stained with toluidine blue or safran-
ine blue for light microscopic analysis. Damage to 
the articular cartilages was evaluated according to a 
modified Mankin score as recommended by the Os-
teoarthritis Research Society International (OARSI) 
for histological assessment of osteoarthritis in sheep 
(Table 4)83.
Table 3.  The histological-histochemical grading system according to Mankin.
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Table 4  -  Modified Mankin according to ICRS recommendations 
Microscopic scoring of cartilage Score
STRUCTURE
(score the worst area 
in field of view) 
Normal 0
Slight surface irregularities (surface barely disturbed) 1
Moderated surface irregularities (surface roughened) 2
Severe surface irregularities (disruption, fissuring/ fibrillation to less than 10% depth) 3
Fissures to transitional zone (1/3 depth) 4
Fissures to radial zone (2/3 depth) 5
Fissures to calcified zone (full depth) 6
Erosion or severe fibrillation to mid-zone (1/3 depth) 7
Erosion or severe fibrillation to deep-zone (2/3 depth) 8
Erosion or severe fibrillation to calcified-zone (full depth) 9
Erosion or severe fibrillation to subchondral bone 10
 CONDROCYTE DENSITY 
(average score for 
whole field of view in 
non-calcified cartilage)
Normal 0
Increased or slight decrease 1
Moderate decrease 2
Severe decrease 3
No cells 4
CELL CLONING  
(score the whole field 
of view)
Normal 0
Several doublets 1
Many doublets 2
Doublets and triplets 3
Multiple cell nests or no cells in section 4
Interterritorial Tolouidine blue 5
INTERTERRITORIAL 
TOLOUIDINE BLUE 
(score the worse area 
in field of view working 
from AC surface down)
Intact 0
Decreased staining to mid-zone (1/3 depth) 1
Decreased staining to deep-zone (2/3 depth) 2
Decreased staining to calcified-zone (full depth) 3
No staining 4
TIDEMARK 
(score the worst area 
in field of view)
Intact subchondral bone plate + single tidemark 0
Intact subchondral bone plate + duplicated tidemark 1
Blood vessel penetrate thru subchondral bone plate to calcified cartilage 2
Tidemark penetrated by blood vessels 3
Table 4.  Histological classification used to evaluate cartilage damage of joint compartments.
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TABLE 5 - Cartilage health adjacent to the implant
MACROSCOPIC EVALUATION Score
Cartilage Abutting 
Implant
Complete 2
Disrupted < 50% 1
Disrupted > 50% 0
Abuttting Cartilage 
Appearance
Smooth 2
Fibrillations 1
Erosions 0
Cartilage Colour Abut-
ting the Implant
Bluish hyaline-like 2
White 1
Yellow 0
Cartilage Flow Yes 1
No 0
MICROSCOPIC EVALUATION Score
Cartilage Integration 
with Implant
Complete integration 3
Demarcation line < 50% 2
Demarcation line > 50% 1
Gap or cyst 0
Implant Level with 
Surrounding Cartilage
Recessed < 25% 2
Recessed < 50% 1
Protruding or recessed to subchondral bone 0
Degenerative Change 
of Adjacent Cartilage
Normal cellularity, no cluster, normal staining 2
Moderate cellularity, some cluster, moderate staining 1
Severe hypocellularity, many clusters, severe destaining 0
4.3.5.2 Cartilage health surrounding the implant 
To evaluate the health of the cartilage bordering the 
implant a score was formed using both macroscopic 
and microscopic parameters (Table 5). Parameters 
were modified from existing cartilage repair clas-
sifications92-94. For details please see Paper IV. We 
propose that a score of 10-14 points suggests satis-
factory result, 5-9 points moderate result and a score 
of 0-4 point denotes unsatisfactory chondrointegra-
tion (Table 5). 
4.3.5.3 Evaluation of cartilage defect
The defects were evaluated macroscopically using 
high-resolution photographs according to ICRS 
cartilage repair score (Table 6) and microscopical-
ly according to O´Driscoll cartilage repair score 
(0-24)28,93. 
Table 5.  Score developed to assess cartilage health surrounding the implant.
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TABLE 6 -  Cartilage repair assessment 
Score
DEGREE OF DEFECT 
REPAIR
In level with surrounding cartilage 4
75% repair of defect depth 3
50% repair of defect depth 2
25% repair of defect depth 1
0% repair of defect depth 0
INTEGRATION TO 
BORDER ZONE
Complete integration with surrounding cartilage 4
Demarcating border < 1 mm 3
3/4 of graft integrated, 1/4 with a notable border > 1 mm width 2
1/2 of graft integrated, 1/2 with a notable border > 1 mm width 1
From no contact to 1/4 of graft integrated with surrounding cartilage 0
MACROSCOPIC  
APPEARANCE
Intact smooth surface 4
Fibrillated surface 3
Small, scattered fissures or cracks 2
Several, small or few but large fissures 1
Total degeneration of grafted area 0
Overall Repair Assessment Score
Grade I Normal 12
Grade II Nearly normal 8-11 
Grade III Abnormal 4-7
Grade IV Severly abnormal 0-3
Table 6.  ICRS Cartilage Injury Evaluation Package. Used for the evaluation of untreated cartilage defects. 
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4.4.1 Micro-CT
Micro-computed tomography (CT) is x-ray ima-
ging in 3-D, similar to regular CT used in hospitals 
but with significantly higher resolution (Fig. 30). 
Like 3-D microscopy small-scale structures (in the 
micron range) can be visualised non-invasively. As 
the object rotates producing hundreds of different 
angular views a computer produces virtual cross-se-
ctional slices. The region of interest can then be 3-D 
analysed in several morphometric parameters such 
as bone architecture, density and quality95,96.
Figure 30.  A photograph showing a micro-CT image (left) of an implant inserted into the medial femoral condyle and a 3-D 
reconstruction (right) useful to evaluate bone features.
4.4 Bone quality and osseointegration
4.4.2 Bone histomorphometry 
While histology is commonly descriptive, quantita-
tive measurements are of importance when evalu-
ating bone tissue. Bone histomorphometry offers 
quantitative study of the microscopic organisation 
and structure of bone through computer-assisted 
analysis of images formed by microscopy. Quantita-
tive analysis of bone architecture provides valuable 
information on the amount of bone and its cellular 
activity. In our experiment several bone parameters 
were evaluated such as osteolytic bone areas, stress 
shielding, osteid bone, bone density and bone to 
implant contact. 
For methods on the evaluation of osseointegration 
and data in detail see Methods in Paper II. In sum-
mary, the medial femoral condyle containing the im-
plant was prepared for light microscopy, according 
to the ground sectioning technique by Donath and 
Breuner and embedded in plastic (not paraffin)97. 
The sections were stained with Sanderson’s RBS 
stain and counter stained with acid fuchsin (both 
Dorn & Hart, USA). The specimens were examined 
with a Zeiss Supra VPN-40 field cathode scanning 
electron microscope using the backscatter detector 
described in the following section. The resulting 
images were evaluated using ImageAccess (Imagic, 
Switzerland) software. The measurement was started 
from the first bone to implant contact at the left 
side of the hat around the body of the implant to 
the first bone contact at the right side. The amount 
of the bone-to-implant contact was measured in 
percent.
4.4.3 Backscatter electron microscopy
Backscatter electron detectors are commonly used 
in association with scanning electron microscopy. 
The detector is placed above the sample in a cham-
ber and detects the scattered electrons from the 
interaction of the accelerated electron beam with 
the sample (atoms), explained like “billiard balls” 
(electron) colliding with larger particles (atoms). 
This produces a scatter that is proportional to the 
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Figure 31.  Backscatter electron detectorphotograph showing a compositional image. Metal produces brighter image.
4.5 STATISTICAL METHODS
”Your sample size is small, your standard deviation is large, your conclusions mean nothing”
Homer Simpson
Data are presented as means with their range, stan-
dard deviation (SD), estimated 95% confiden-
ce intervals or shown in box-plots. A two-factor 
analysis of variance (ANOVA) model was used to 
compare cartilage damage related to operative tre-
atment and across time (Paper III) or to compare 
cartilage damage related to operative treatment and 
joint location (Paper IV), and interactions between 
those factors. Independent samples Student´s t-test 
was used to compare means between groups. For 
non-parametric values the Mann-Whitney U test 
for ranked values was used to compare results at dif-
ferent time points and Wilcoxon signed ranked test 
for matched pairs, respectively. Fischer’s exact test 
was used to compare counts of individuals with or 
without significant changes. Linear regression was 
used to assess the relationship between implant po-
sition and cartilage damage; means for each animal 
were used as independent samples (Paper I) or to as-
sess the relationship between cartilage damage and 
age (Paper III). P-value was set at 0.05. Calculations 
were performed using STATA v12.1 or SPSS 15.0 
for Windows statistical package.
atomic size: thus larger atoms produce brighter 
backscatter electron intensity and particles while a 
smaller atomic size produce darker images. Backsca-
tter electron detectors provide high-resolution com-
positional images of a particular sample (Fig. 31)98.
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5 RESULTS
5.1 PAPER I
Twenty-two knees in eleven animals were available 
for macroscopic and microscopic evaluation, and 
because two samples could not be digitised, 20 kne-
es remained for laser measurement. No histological 
differences in opposing tibial cartilage were seen 
between the two types of implants used (P = 0.82; 
from 10 samples of comparable implant heights). 
Mankin score after twelve weeks did not grossly dif-
fer from six weeks (mean 6.7, 5.5, respectively, P = 
0.61; batch 1). Therefore data are presented as one 
pooled group of implants.
5.1.1 Implant position
Height of implants (n = 20) as assessed by the mean 
of the three transversal data points from laser scans 
averaged standard deviation (SD) -0.20 (0.66) mm 
in the group aimed at flush position, -0.33 (0.18) 
in the group aimed for 0.3 mm recessed and -0.76 
(0.12) in the group aimed for 0.7 mm recessed, re-
spectively. Implant position expressed with the ai-
med offset level subtracted, averaged for the merged 
group, was -0.12 (0.47) mm. In fact 80% of the im-
plants were placed somewhat lower than aimed for 
but some implants protruded up to 0.7 mm above 
the intended position.
5.1.2 Macroscopic cartilage evaluation
Macroscopic score (n = 11) averaged (range) 1.7 
(1-3). Macroscopic score as a function of implant 
position showed a linear relationship (P = 0.01) 
such that International Cartilage Research Society 
(ICRS) score increased by 1.2 (95% conf. int: 0.4, 
2.0) units per each mm increase in implant height.
5.1.3 Microscopic cartilage evaluation
Histological preparation showed a varying degree 
of surface damage. Modified Mankin score (n = 
11) averaged (range) 4.8 (1-10), and protruding 
implants showed higher Mankin score (P < 0.01). 
Microscopic score as a function of implant position 
showed a linear relationship (P = 0.008) such that 
Mankin score increased by 4.3 (95% conf. int: 1.5, 
7.0) units per each mm elevation in implant height.
5.2 PAPER II
Joint health as indicated by the modified O’Dris-
coll score showed no changes in range of motion 
(ROM), fibrosis or cartilage appearance (average 
0.0 out of maximum 6 points at 6 or 12 months). 
Likewise ICRS macroscopic score of the tibial sur-
face showed no damage (average 0.0 points out of 
maximum 4 points) at 6 months and 0.67 (95% CI: 
-0.16, 0.51) points following 12 months indicating 
no statistical significance (Z = 0.77; <1.96).
5.2.1 Micro-CT evaluations
At 6 months one specimen out of three showed 
small osteolytic areas beyond the hat, whereas the 
peg was always firmly osseointegrated. The other 
two specimens were completely osseointegrated. At 
12 months, two specimens out of six showed small 
osteolytic areas at the hat. One specimen showed 
enlarged bone marrow chambers. The remaining 
three specimens were completely osseointegrated.
5.2.2 Histomorphometry
Stained ground sections cut longitudinally through 
the centre of the peg showed functionally osseointe-
grated implants after both 6 and 12 months, respec-
tively. At both time points, a high bone-to-implant 
contact was measured with a mean of 90.6% (95% 
CI: 79.4, 101.9) at 6 months and 92.3% (95% CI: 
89.5, 95.2) at 12 months, respectively, indicating no 
statistically significant difference (Z = 0.00; <1.96). 
The mean bone density in a 500 micron wide band 
adjacent to the implant surface was 72.5% (95% CI: 
60.0, 85.0) at 6 months and 75.4% (95% CI: 67.3, 
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83.5) following 12 months, respectively indica-
ting no statistically significant difference (Z = 0.60; 
< 1.96). In the corresponding section of normal host 
bone distant to the implant the mean bone density 
was 63.0% (95% CI: 58.1, 68.0) at 6 months and 
48.7% (95% CI: 43.3, 54.2) following 12 months, 
respectively.
5.3 PAPER III
Joint health as indicated by the modified O’Driscoll 
score showed no changes in ROM, fibrosis or car-
tilage appearance (average 0.0 out of maximum six 
points at 6 or 12 months).
5.3.1 Implant position
Height of implants (n = 12) as assessed by the mean 
of three transversal and three anteroposterior data 
points in the implant measured from laser scans, av-
eraged 0.54 mm recessed (95% CI: 0.41, 0.67) with 
a standard deviation (SD) of 0.23 mm for the whole 
group aimed at 0.5 mm recessed. Further, the mean 
frontal (transversal) and sagittal (anteroposterior) 
tilt was 0.03° (95% CI: -2.08, 2.14) (SD 3.73) and 
0.25° (95% CI: -2.09, 2.60) (SD 4.15), respectively.
5.3.2 Macroscopic cartilage evaluation
The macroscopic evaluation (Outerbridge 0-4) of 
the medial tibial cartilage surface showed modest 
cartilage damage both in the surface opposing the 
implants 0.45 (range 0-3) and in the control knee 
0.50 (range 0-2) with no statistically significant 
difference between sides (Z = -0.14). Lateral tibia 
and femoral surface showed no or minor damage. 
Likewise, the tibial surface opposing the implant 
showed no damage across time; average 0.29 (range 
0-1) at 6 months; and 0.67 (range 0-3) points fol-
lowing 12 months indicating no statistical signifi-
cance (Z = 0.43; < 1.96).
5.3.3 Microscopic cartilage evaluation
The tibial plateaus of both the operated and the con-
trol knee showed a varying degree (range 0-17 units) 
of articular cartilage damage evaluated according to 
the Modified Mankin score as recommended by 
OARSI (0-27 units). Cartilage damage of the me-
dial tibial plateau showed a linear increase with age.
Cartilage damage of the medial tibial plateau op-
posing the implant was increased compared to the 
medial tibia of the non-operated knee by a statisti-
cally significant difference of 1.77 units (P = 0.041; 
95% CI: 0.08, 3.45). Tibial Mankin score of the 
12-month group (n = 6) was 1.85 units higher when 
compared to the 6-month group (n = 7), however 
this did not reach statistical significance (P = 0, 42; 
95% CI: -2.98, 6.68). Also, no interaction between 
implant and time was observed (P = 0.94). The tibi-
al cartilage of the lateral compartment was substan-
tially less damaged than the medial compartment 
in both the operated knee, by 4.2 units (P = 0.007; 
95% CI: 1.38, 7.13), and the non-operated knee by 
2.40 units (P = 0.03; 95% CI: 0.29, 4.50). There 
was no difference in tibial cartilage damage of lateral 
compartments between operated or non-operated 
knees (0.09 units, P = 0.86; 95% CI: -1.02, 1.19). 
Five out of 13 (38%) animals showed a difference of 
4 or more Mankin units between their medial tibial 
surfaces. This did not reach statistical significance 
(Fischer’s exact test; P = 0.59).
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5.4 PAPER IV
Joint health as indicated by the modified O´Dris-
coll score showed no changes in ROM, fibrosis or 
cartilage appearance (average 0.0 out of maximum 
six points).
5.4.1 Implant position
Height of implants (n = 6) as assessed by the mean 
of three transversal and three antero-posterior data 
points in the implant measured from laser scans, av-
eraged 0.60 mm recessed (range 0.16-0.82) with a 
standard deviation (SD) of 0.23 mm for the who-
le group (aimed at 0.5 mm recessed). Further, the 
mean frontal (transversal) and sagittal (anteropos-
terior) tilt was 3.7° (range 0.4-7.3) and 2.6° (range 
0.8-4.6). 
5.4.2 Macroscopic cartilage evaluation
The macroscopic cartilage evaluation (Outerbridge 
0-4) of the medial tibial cartilage surface showed 
modest cartilage damage both in the surface oppo-
sing the implants 1.6 (range 0.5-4) and in tibia op-
posing the untreated defect 0.9 (range 0-1.5) with 
no statistically significant difference between sides 
(Z = 0.707, P = 0.480). Lateral tibia and femoral 
surface showed no or minor damage macroscopical-
ly.
 
5.4.3 Microscopic cartilage evaluation
The opposing tibial plateaus of both the trea-
ted and untreated defect showed a varying degree 
(range 1-15) of articular cartilage damage evaluated 
according to the Modified Mankin score as recom-
mended by OARSI (0-27 units). 
Cartilage damage of the medial tibial plateau oppo-
sing the implant showed no statistically significant 
difference (P = 0.51; 95% CI: -3.7-6.5) compared 
to the medial tibial plateau opposing the non-trea-
ted defect of the contralateral knee. Using repeated 
measures ANOVA we showed a statistically signifi-
cant difference in cartilage damage between different 
joint compartments. The medial femoral compart-
ment was significantly less damaged compared to 
medial (P = 0.02; 95% CI: 0.45-8.14) or lateral tibial 
compartments (P = 0.004, 95% CI: 1.59-5.00). The 
tibial cartilage of the lateral compartment showed 
no statistically significant difference compared to 
the medial compartment (P = 0.51, 95% CI: -4.61-
2.61). Differences between compartments were not 
related to treatment with implant or left untrea-
ted (P = 0.38). A post-hoc comparison in a pooled 
group of twelve young sheep showed no statistically 
significant difference (P = 0.32) between medial and 
lateral compartment in knees treated with implants. 
5.4.4 Cartilage health adjacent to the implant 
Cartilage health adjacent to the implant scored ma-
croscopically (n = 12) averaged 6.5 (range 5.0-7.0) 
with a SD of 0.72 and averaged microscopically 
(n = 10) 5.5 (range 3.0-6.5) SD (1.01). When poo-
led together (n = 10) the total score averaged 11.3 
(range 9-13) with a SD of 1.46.
5.4.5 Cartilage repair of the defect
Cartilage repair of untreated defects scored macro-
scopically (n = 6) on average 5.0 (range 0.5 – 5.0) 
and microscopically (n = 6) on average 8.0 (range 
2.0-14).
5.4.6 Histomorphometry
Bone-to-implant contact (BIC) averaged 79.3% 
(range 41.9-98.8). 
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6 DISCUSSION
The treatment of deep focal condylar lesion of a vo-
lume of approximately 550 mm3 (area of 2-4 cm2) 
in the middle-aged patient remains a clinical chal-
lenge8. For the last three decades the gold standard 
approach to treat these lesions has been biological 
treatment. The aim is to reconstitute a long-lasting 
structural and functional cartilage tissue that resem-
bles natural hyaline cartilage. However, it has not 
been possible to entirely reproduce the complex 
structure of articular cartilage, specifically the colla-
gen and proteoglycan interaction. Therefore instead 
of the biological approach we opted for a biomecha-
nical strategy by resurfacing cartilage lesions with a 
metal implant (FKRM). Similar to the treatment of 
tooth caries we aimed to fill the cartilage void with 
inorganic material. This method bridges the gap 
between biological treatment at a younger age and 
joint replacement at the end of the OA road.
6.1 IMPLANT DESIGN
Co – Cr material has been a widely used biomaterial 
for orthopaedic implants in the last decades proving 
its efficacy and biological safety. Also, in order to 
avoid drawbacks of modular systems such as cor-
rosion and fatigue failure at the junction between 
the hat and the peg, we needed a strong material 
that permitted building the implant as a monobloc. 
Co – Cr alloys have proven to have excellent fatigue 
strength and corrosion resistance even in a chloride 
environment (such as body fluids) when compared 
to other materials99.
The contour of the implant was our next concern. 
Based on mathematical calculations (finite ele-
ment analysis; FEA), we concluded that an implant 
should follow the contour of the femoral condyle 
and be somewhat recessed in relation to surroun-
ding cartilage100,101. It is easier to achieve this goal 
if the articulating surface is double-contoured, as 
it more accurately mimics the natural curves of the 
femoral condyle in all planes. A single radius con-
tour would require an excessive recession in order 
not to protrude at any point of its surface. All im-
plants were circular mainly because of the difficulty 
to ream individualised shaped defects perpendicular 
to the condyles in all planes. 
Friction of the articulating surface was another con-
cern. Hyaline cartilage provides an almost fric-
tionless surface with a coefficient of friction in the 
order of 0.0025 (compared to rubber on concre-
te 1.0, Teflon on Teflon 0.04, or ice on ice 0.02). 
Biomaterials regularly used in orthopaedics are not 
close to matching the cartilage friction coefficient. 
For example polished steel on ultra high molecu-
lar weight polyethylene (UHMWPE) has a friction 
coefficient of 0.05. A five-axial milling device was 
used to shape the double-curved contour of the ar-
ticulating surface, leaving a stepwise structure when 
observed at higher magnification. The surface was 
therefore highly polished to a Ra of 0.04 μ, me-
eting the required International Organization for 
Standardization (ISO) standard of Ra of 0.05 for 
Co – Cr alloys used in articulating orthopaedic im-
plants. 
The fixation of the non-cemented implant to under-
lying bone is vital for the success of this concept. 
Primary fixation was intended by a slender press-
fit peg into an undersized predrilled hole. Others 
used a modular system with a large screw anchoring 
to the underlying bone61,64. We tried an alternative 
design with a thread-like shape of the peg to increa-
se the contact peg-bone area similar to others88. In 
our series however, this design offered no benefit 
but rather decreased the percentage of implant that 
was ossoeintegrated. Long-lasting secondary fixa-
tion was intended by use of a double-coated plasma 
sprayed Ti – HA layer.
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6.2 CONTACT PRESSURES AND BIOMECHANICS
Fundamental for successfull result when resurfa-
cing a full depth focal condylar lesion is that the 
implant must not increase the peak contact pressure 
causing damage to opposing tibial cartilage. Becher 
et al. showed that a proud implant would increa-
se the contact peak pressure on opposing tibia by 
approximately 200% compared to an untreated 
defect. An implant seated flush did not show in-
creased contact peak pressure102. The presence of a 
meniscal tear increased the peak contact pressures 
by about 80% compared to an implant seated flush 
with normal meniscus103. Furthermore, when tested 
dynamically they concluded that an FKRM implant 
seated recessed did not produce deleterious effect 
on opposing cartilage104. To study the behaviour of 
the cartilage surrounding the implant Manda et al. 
developed a finite element mathematical model and 
tested both the spherical first generation implant 
and the double contoured second-generation Epi-
sealer® FKRM. Both implants showed favourable 
effect compared to an untreated defect when seated 
recessed (0.3 mm) regarding rim stresses. However 
if the implant is seated too deep it may also lead to 
high rim stresses100,101. We therefore aimed implants 
0.5 mm recessed (Paper III-IV) to accommodate for 
surgical imprecision and cartilage compression un-
der dynamic loading (Paper I). 
6.3 INSTRUMENTATION 
We realised that optimal implant positioning 
was of utmost importance for the well-being of 
neighbouring cartilage. A protruding implant 
would plough opposing cartilage whereas an im-
plant which was too recessed would not impede the 
apposing cartilage wall from collapse. An optimally 
positioned implant is dependent on the shape of the 
implant and similar to the knee prosthesis, depends 
on the used instrumentation and guides. A first ge-
neration aiming device was developed using an ex-
ternal hat that aimed to place a guiding pin perpen-
dicular to the cartilage surface, similar to others64. 
It was however not possible to obtain the desired 
position accurately and consistently as demonstra-
ted in Paper I. In this pilot study a significant impre-
cision was noted showing a standard deviation from 
the intended position of 0.47 mm. Based on the 
concept of patient-specific instrumentation (PSI), 
an individualised second-generation aiming guide 
was developed (Fig. 32). Individualised instruments 
adapted to the sheep condyle showed accurate and 
consistent implant placement as demonstrated in 
Paper III.   
Figure 32.  Individualised set of instruments used to achieve 
accurate implant position similar to the set of instruments 
used for the animal studies. Courtesy of Episurf Medical AB.
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6.4 IMPLANT POSITION IN RELATION TO SURROUNDING CARTILAGE
We found that cartilage damage correlated strongly 
with implant position showing a linear relationship 
such that the Mankin score increases by 4.3 units 
per each mm elevation in implant height (Paper I). 
There is enough evidence from FEA, biomechanical 
tests and preclinical studies to state that an implant 
should not protrude62,102-106. There is however no 
consensus on the ideal FKRM implant position and 
most authors aim for implants seated flush62,64. The 
use of an ‘external’ guide system in Paper I showed 
significant imprecision and when aimed flush, in fact 
some implants protruded causing devastating effects 
on opposing cartilage. I therefore recommended, in 
accordance with FEA and our preclinical results, to 
aim implants at a somewhat recessed position (0.3-
0.5 mm). An individualised instrumentation guide 
based on each particular anatomy is recommended 
for optimal implant fit. Accordingly, accurate and 
reproducible measurements of implant position 
play a key role in both development and concept 
evaluation ensuring reliable and repeatable perfor-
mance. Laser scanning technology is widely used 
for this purpose in industry and has a resolution (< 
1 μm) well beyond the requirements for this app-
lication. By digitising the entire condyle including 
the implant, the geometry and the implant position 
within the condyle can be evaluated on the basis of 
graphic colour diagrams (Fig. 33). Among the dif-
ficulties in measuring implant position in terms of 
height related to the cartilage level is the fact that 
the cartilage above the implant is missing. Therefore 
the radii of the condyle have to be calculated from 
the cartilage that surrounds the implant. Because 
the curvature of the condylar surface is not spherical 
(constant) the radii are difficult to calculate107. Two 
different measurement strategies were used to calcu-
late this virtual cartilage plane. First (Paper I), the 
sagittal and transversal radii of the individual con-
dyle were estimated using a large portion (20 mm) 
of the surface bordering the implant. The difference 
in height between these constructed circles and the 
implant surface as determined from five data points 
on the implant was used to describe implant posi-
tion in terms of height (Fig. 33). While the condylar 
radius in the transversal plane is near spherical, it is 
actually J-shaped in the sagittal plane (the radius de-
creases posteriorly). Therefore a radius averaged in 
the sagittal plane corresponds less precisely with the 
true cartilage level. The second measurement stra-
tegy (Paper III-IV) used the radii of the implant to 
construct a cap, which was positioned at the carti-
lage margins to represent the missing cartilage level. 
Figure 33.  This shows the radii at the missing cartilage level  (in violet) based on the curvature (red) of the condyle (left). Pho-
tograph of an adequate implant position (right). 
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6.5 OSSEOINTEGRATION
The slender monobloc implant was designed in or-
der to preserve as much bone as possible, in case 
of need for future surgical interventions. For fixa-
tion purposes a press-fit peg was deemed sufficient 
to achieve primary fixation and then supplemented 
with a double-coating layer (Ti – HA) for seconda-
ry long-lasting fixation. Titanium has proven oste-
oconductive properties and does not dissolve over 
time, providing osseointegration if there are no gaps 
at the bone-implant interface108. In some cases os-
teolysis was found at the hat (Paper II) and it was 
speculated that synovial fluid from the joint pe-
netrated the hat-cartilage interface at insertion. This 
interface was subsequently sealed by HA, by conver-
ting fibrous tissue into bone (circumferential bone 
apposition). HA has a filling effect of a gap up to 
1 mm in both loading and unloading conditions77. 
Moreover, a frame of newly produced trabecular 
bone surrounded these lytic areas indicating a posi-
tive trend towards bone formation. A combination 
of these two compatible osteoconductive materials 
(Ti – HA) would promote osteoactivity in the pre-
sence of gaps regardless of loading condition. A 
double coating with an underlying layer of titanium 
secures long-lasting fixation, should the first HA 
layer dissolve. In fact, a main result of this study was 
the excellent osseointegration of the double-coated 
Ti – HA implant (Paper II). The osseointegration 
was about 90% (average) of the implant surface in 
contact with bone and never less than 40%, which 
is high compared to any other animal or human stu-
dies61,84,109. Hence, the concept of a double-layer on 
a slender monobloc Co – Cr core proved its efficacy 
(Fig. 34). 
6.5 CARTILAGE HEALTH AND CHONDROINTEGRATION AT THE IMPLANT
A prerequisite for FKRM implants to succeed is 
that the host tissue must accept the implant. As 
aforementioned the bone bonded with the implant 
excellently, as shown using accepted histomorpho-
metric methods. There are however no methods to 
assess bonding between implant and surrounding 
cartilage, or an accepted score to quantify cartila-
ge damage when adjacent to a metal implant. Kir-
ker-Head et al. described an absence of cracks or 
fibrillations and cartilage flow over the implant in 
their original pilot study61. In our first experiments 
we noticed that cartilage as well as bone adhered to 
the HA covered perimeter of the hat and a primary 
evaluation showed that most (85%) of the cartilage 
in contact with the HA adhered (Fig. 35, 36). Based 
on this finding the implants were modified in the 
Figure 34.  A microphotograph of an osseointegrated FKRM implant (left) and the intimate bonding between bone (red) to HA 
(brown) and at some points to the Ti-layer (arrow) in areas where the HA have dissolved (right).
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subsequent experiments to cover the entire perime-
ter of the implant with HA, a concept not described 
before. We attempted to construct a classification 
system based on parameters validated for cartilage 
repair (Table 4) to evaluate the efficacy of the carti-
lage to accept the implant. Furthermore, we sugge-
sted a grading score (see Methods in Paper IV) whe-
re 10-14 points suggests satisfactory cartilage health 
and bonding to the implant. All animals evaluated 
according to our method showed satisfactory re-
sults (n = 10; Paper IV). Additionally, it can be hy-
pothesised that the implant prevents collapse at the 
rim of the defect by supporting the walls, as also 
suggested by the absence of fibrillation around the 
implant110. Similar to other researchers, we obser-
ved a metachromatic membrane partially covering 
the implant, a positive phenomenon described as 
matrix flow (Fig. 35, 36)61,110-112. Finally, the sealing 
effect of HA might not only apply to bone but also 
to cartilage, further preventing synovial fluid from 
penetrating to the subchondral bone and potentially 
producing cysts.
Figure 35. Picture of a cross-sectional histological specimen showing proper attachment of cartilage to the HA covered pe-
rimeter of the hat and a gap between the cartilage and the uncoated perimeter of the implant (left). High-resolution photo-
graph showing a macroscopic image of healthy cartilage adjacent to the implant (right). 
Figure 36. Note the metachromatic cartilage flow on top of the implant (left), and shown macroscopically on a high-resolution 
photograph (right).
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Figure 37.  Picture of a cross-sectional histological specimen showing an unhealed cartilage defect at six months (left). 
High-resolution photograph showing macroscopic view of the same defect (right).
6.7 CARTILAGE DEFECTS
It is acknowledged that focal cartilage defects can 
cause pain and dysfunction. According to Heir et 
al. these patients reported more discomfort than 
patients with anterior cruciate ligament-deficiency, 
and their quality of life was just as affected as in pa-
tients scheduled for knee replacement113. However, 
it should be remembered that articular cartilage de-
fects may also be asymptomatic and the likelihood 
of a defect becoming symptomatic is unknown114-116. 
Shelbourne et al. assessed the natural history of focal 
deep lesion grade III–IV left untreated and compa-
red them to a matched control group. After 6.5-year 
follow-up the patients with defects had slightly but 
significantly lower subjective scores than controls, 
and 79% returned to jumping or pivoting recrea-
tional sports. The authors concluded that most pa-
tients had few symptoms and the results could be 
used to compare results from procedures treating 
articular defects117. It has been recognised that full 
depth and even superficial cartilage lesions do not 
heal and might progress to generalised OA57,118,119. 
In Paper IV it was established that a created full 
depth cartilage lesion ICRS grade IV does not heal 
(Fig. 37). There was no evidence of repair according 
to the evaluation using a validated repair score and 
some defects showed signs of rim collapse. Thus the 
experimental model comparing untreated to defects 
treated with FKRM implants is motivated.
In Paper IV we hypothesised that an untreated de-
fects would disturb joint homeostasis while a defect 
treated with a FKRM implant would interrupt the 
OA progression. In our paper we could not show 
this progression and we believe this was due to the 
small numbers of animals and the short six-month 
follow-up time.
6.8 OPPOSING AND DISTANT CARTILAGE HEALTH
In a pioneering pilot study, Kirker-Head et al. no-
ted fibrillation and erosions of the goat tibia ar-
ticulating towards a Co – Cr FKRM implant61. 
However, they noted fibrillation and erosion in the 
contralateral non-operated knee as also observed in 
other species120. It was argued that cartilage degene-
ration was related to implant elevation but quan-
tification of implant position or histological carti-
lage scores was not reported. However the authors 
concluded that screw-anchored FKRM (Hemicap® 
Arthrosurface) implants caused less cartilage dama-
ge when compared to other studies on biological 
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resurfacing methods61. In two other studies evalu-
ating the effects of FKRM implants on opposing 
tibia, Custers et al. reported significant cartilage 
degeneration84,106. In their first study, histological 
cartilage degeneration of the tibia cartilage oppo-
sing an oxidized zirconium (OxZr) implant scored 
eight units (scale 0-24) compared to twelve units in 
a group that had a focal defect microfractured106. In 
the subsequent study they reported cartilage dama-
ge to opposing tibia corresponding to twelve units 
(scale 0-24) regardless of the bearing material (Co 
– Cr or OxZr) or if the defect was left untreated. 
These data were compared to eight units of cartila-
ge degeneration in a healthy non-operated control 
group (surprisingly these data were from a separate 
unpublished study). In our studies we also found a 
statistically significant but modest difference in car-
tilage degeneration of opposing tibia by two units 
(scale 0-27) compared to the non-operated control 
knee (Fig. 38), despite accurate implant position 
(Paper III). The results from Custers et al. could be 
considered satisfactory considering no use of instru-
mentation guide was reported. Cartilage damage to 
opposing tibia could in fact be secondary to implant 
malposition such as tilt or protrusion. Furthermo-
re no postoperative measurements of implant po-
sition were reported84,106. Interestingly, all research 
groups report certain damage to cartilage surfaces 
within the knee regardless if defects were treated 
or left untreated and even in non-operated healthy 
controls. Additionally, almost no human or animal 
studies of femoral cartilage defects and their biologi-
cal treatment report data on opposing tibia. Custers 
et al. found a similar amount of cartilage degenera-
tion opposing defects treated with implants or left 
untreated. In Paper IV we compared defects treated 
with FKRM implants or left untreated and obser-
ved a similar amount (six units in a 0-27 scale) of 
damage to opposing tibia. Unfortunately, implants 
were at a slightly inaccurate position either by tilt or 
by over-recessing, with one tilted implant causing 
devastating effects on opposing tibia. Summarising 
our data (Paper III-IV), cartilage degeneration of 
opposing tibia averaged 7-9 units regardless of im-
plant position or age. This should be compared to 
a 5-8 unit cartilage degeneration of opposing tibia 
in healthy controls or untreated defects, respective-
ly. These differences in cartilage degeneration were 
considered acceptable considering that full depth 
cartilage lesions remain a clinical challenge in the 
symptomatic middle-aged patient group where an 
alternative treatment option is lacking.
It can be hypothesised that FKRM treatment ham-
pers the progression to generalised OA. This is not 
what other authors have found who showed progres-
sion of degenerative changes to lateral compartment 
in knees treated with implants or microfracture84,106. 
In these studies defects were treated after 10 weeks 
by either an implant or microfracture, similar to the 
clinical situation where treatment delay is common. 
It can be speculated that progression to the lateral 
compartment seen in their studies can be the conse-
quence of this delay. We, however, did not observe 
progression of degenerative changes in our non-tre-
ated defects after treatment with FKRM implants or 
when leaving defects untreated. The short follow-up 
time of untreated defects (Paper IV) might have ob-
scured long-term cartilage degeneration. Moreover, 
it was suggested from our studies that degenerative 
changes on cartilage articulating against a FKRM 
implant was mechanical and had a local effect on 
opposing tibia, whereas remaining joint surfaces 
were unaffected. Additionally, cartilage degenera-
tion on opposing tibia did not progress over time 
(Paper III). Thus, having an implant in the medi-
al femoral condyle did not disrupt the panarticular 
joint homeostasis. 
It is recognised that goats as young as two years old 
show signs of early OA but this has not been shown 
in sheep. In the studies performed by Custers and 
Kirker-Head only young goats (2-3 years old) were 
used and therefore their results were not influenced 
by age61,84,106. In Paper III we used skeletally matu-
re ewes (2-6 years old) and observed a varying de-
gree of cartilage degeneration in both operated and 
non-operated knees. In a post-hoc analysis we sug-
gested that there was a linear relationship correla-
ting cartilage damage to age in sheep. This should be 
considered when evaluating results of cartilage de-
fects studies. Consequently, in Paper IV only young 
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ewes (2-3 years old) were used and no difference in 
cartilage damage of the tibia articulating against a 
metal implant or an untreated defect was observed. 
Furthermore, there was no difference in cartilage 
damage between medial to lateral compartments, in 
contrast to what was observed in Paper III. We sug-
gested that this could be age-related. When perfor-
ming a post-hoc comparison using all twelve young 
sheep no difference in cartilage damage between 
medial and lateral compartment was observed. In 
Paper IV, the lateral compartments showed cartilage 
degeneration similar to those seen earlier (Paper III) 
in non-operated healthy control knees. Older ewes 
show more cartilage degeneration, often more pro-
nounced in the medial tibia, whereas younger ewes 
show similar amount of cartilage degeneration in 
the whole knee. We speculated that this minor car-
tilage damage, often fissures, represented the young 
ewes’ cartilage healing capacity to maintain joint 
homeostasis. 
Figure 38.  Cross-sectional histological photographs. Note minor differences between the tibial cartilage opposing an implant 
(left) and the tibial cartilage opposing the non-operated control knee (right).
6.9 SIMILAR CONCEPTS
The concept of a unipolar metal implant articulating 
against cartilage tissue is not new. Hodge presented a 
case where a moulded vitallium distal femur arthro-
plasty, inserted cementlessly, withstood the test of 
time and was still functioning after 30 years121. Har-
rington presented (1992) 28 patients treated with 
resurfacing arthroplasty using the McKeever prost-
hesis for advanced arthritis of the patella. Seventeen 
rated good or excellent at five years according to a 
patella score122. Another concept that has reached 
acceptance is minimally invasive knee arthroplasty, 
which offers the advantages of reduced pain, hospi-
tal stay, morbidity with faster rehabilitation and in-
creased range of motion compared to standard knee 
arthroplasty123,124. Siguier et al. reported (2001) the 
results using a partial surface replacement for osteo-
necrosis of the femoral head with a minimal soft tis-
sue disruption and bone resection in 33 patients fol-
lowed 40 months. Nine failures were attributed to 
expansion of the osteonecrosis, and 24 of 28 survi-
ving implants rated excellent or good according to a 
hip score125. The authors concluded that surgery was 
relatively simple, with minimised soft tissue damage 
and preserved bone stock allowing for immediate 
weightbearing. Should failure occur, a conversion to 
hip arthroplasty was deemed simple considering the 
preserved tissues125. A low profile modular unipo-
lar focal knee resurfacing implant was presented by 
Hemicap® (2003) and a first pilot study in animals 
and humans showed promising results64,61. Conco-
mitantly, Custers et al. presented a similar concept 
using a monobloc unipolar focal knee resurfacing 
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implant that was tested in animal models. The 
authors showed cartilage degeneration following 
treatment with the metal implant and research in 
humans was not conduct88. The last two methods 
have been discussed elsewhere throughout the the-
sis. A flurry of different implant choices is progres-
sively being developed such as UniCap® (similar to 
HemiCap) with an additional polymer tibia inlay, 
ConforMIS® (personalised knee resurfacing prost-
hesis), Orthoglide® (Co – Cr tibia inlay only), just 
to mention some. The combination of minimally 
invasive knee surgery techniques with focal metal 
implants seems an attractive treatment option, but 
still preclinical and clinical studies are scarce.
6.10 LIMITATIONS
The major limitation of this study was the small 
number of animals available; this was both for ethi-
cal, and economical reasons. For instance, the use 
of a bilateral model in the pilot study increased the 
number of knee samples, although we were aware 
that they were not independent individuals. One 
post-hoc analysis included animals from two expe-
rimental series. Also, some animals were lost to fol-
low-up, which might become critical in large-ani-
mal studies with often reduced number of animals.
The short follow-up time (Paper IV) limited the 
comparison and assessment of OA progression in 
knees with untreated defects. However, previous 
studies have shown OA progression with a similar 
amount of animals.
Two slightly different histological scores were used 
to evaluate cartilage damage in Paper I and Paper 
III-IV, which limited the possibility to compare re-
sults. There was no defined strategy on how to ana-
lyse cartilage health adjacent to the implant. Moreo-
ver, there is still no standardised score for evaluating 
cartilage adjacent to an implant. The proposed ma-
croscopic and microscopic evaluation score is not 
validated.
The animals were operated with a guide standar-
dised for one sheep, rather than individualised for 
each animal, for practical and economical reasons. 
This could result in a somewhat less optimal im-
plant position and negatively affect the results. We 
made no comparative study with other treatment 
models such as allogenic mosaicplasty (which is the 
most similar to our method) or the standard treat-
ment (microfracture).
Translating results from animal studies to humans 
is a delicate matter. Sheep have thinner cartilage 
layers, and defects are possible to make only in the 
lower range of what is judged clinically significant 
for humans. Also, they cannot report subjective data 
and functional outcome measures cannot be asses-
sed.
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6.11 CONLUSIONS
A monobloc double-curved and double-coated 
(Ti – HA) Co – Cr implant is presented. Both im-
plant and instrumentation for the treatment of full 
depth focal cartilage lesions in the femoral condyle 
was developed successfully for testing in a translatio-
nal sheep animal model. 
A firm and consistent bond to bone under weight- 
bearing conditions in all of the evaluated cases was 
obtained. Therefore, the results of this study sup-
port the use of this double-coated construct. More-
over, we noted signs of adherence between cartilage 
and the HA-covered area of the implant, indicating 
a possible bonding between HA and cartilage. In an 
attempt to evaluate the health of the cartilage that 
surrounded the implant we proposed a score and 
showed satisfactory results in terms of integration 
between host-tissue and implant. We confirmed that 
untreated defects do not heal. However, our study 
did not have the power to prove OA progression of 
untreated cartilage defects to distant compartments. 
Implant precision is hard to achieve and damage to 
opposing tibia is distinctively sensitive to implant 
position, and it is emphasised that implants should 
never protrude. With ‘individualised’ aiming gui-
des an accurate and consistent implant position was 
achieved. Using this position there was limited da-
mage to opposing tibia that did not increase over 
time. Having an implant did not disturb the general 
joint cartilage homeostasis; hitherto the effects of an 
implant on cartilage degeneration are acceptable.
The biological safety of a novel FKRM implant in a 
large animal model and its efficacy in terms of fix-
ation, integration to host tissue and cartilage joint 
homeostasis was studied. Based on these scientific 
data, human studies aimed to evaluate treatment of 
symptomatic middle-aged patients with full-depth 
focal cartilage lesion in the medial femoral condyle 
are motivated. However, the clinical and natural 
history of these lesions is not completely understood 
and we could not show OA progression at short-
term. Hence, we can not advice for prophylactical 
treatment of asymptomatic patients with focal car-
tilage lesions until further research data is at hand.   
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6.12 SAMMANFATTNING PÅ SVENSKA
Bakgrund: Knästukningar vid idrott, i arbetsliv el-
ler trafik leder ofta till invalidiserande broskskador. 
Trots modern biologisk behandling kan dessa skad-
or utvecklas till smärtsam degenerativ ledsjukdom 
(artros), som på sikt kan kräva inoperation av konst-
gjord led (knäprotes). Genom ett tvärvetenskapligt 
medicintekniskt samarbete har en behandlingsme-
tod med syftet att försluta centimeterstora brosk-
defekter med metallimplantat vidareutvecklats. Ett 
nytt implantat med instrumentering och de resul-
terande effekterna på knäleden har sedan studerats 
genom djurexperiment hos får. Ett övergripande 
mål är att lindra belastningssmärta samt förbättra 
funktion och livskvalité efter knäskador med brosk-
defekter. Speciellt medelålders patienter som ännu 
ej är lämpliga för knäprotes saknar behandlingsal-
ternativ. På sikt är förhoppningen att artrosutveck-
lingen kan bromsas. 
Hypotes: Med exakt kirurgisk insättning av metall- 
implantat kan beninväxt uppnås samt broskskador 
förseglas utan att omgivande brosk i leden skadas. 
Metod: Ett dubbelkurverat metallimplantat 
(Co – Cr) med undersidan belagd av titan-hydrox-
yapatit (Ti – HA) opererades in i mediala femur-
kondylen hos totalt 37 tackor i tre experimentserier. 
Beninväxt mättes med histomorfometri. Implantat-
position i form av höjd och vinkel uppmättes ge-
nom laserscanning. Broskkvalitet och defekter be-
dömdes makroskopiskt och mikroskopiskt. Fårens 
hälsa bedömdes av veterinär. 
Resultat: En pilotstudie påvisade varierande implan-
tatposition och att broskskadan på motstående ti-
biayta var linjärt korrelerad till höjdfelställningen, 
och att ett implantat inte skall sticka utanför led-
broskytan. En serie av andra generationens indivi-
danpassade metallimplantat kunde placeras med 
hög precision; 0.54 mm nedsänkt, och att brosks-
litaget då var acceptabelt efter första året. Likaledes 
var brosket intill implantatet oskadat och vidhäftigt 
på implantatets HA beklädda yta. Broskkvaliteten 
i knäets övriga ledytor visade inga tecken på slitage 
i denna långtidsstudie. En obehandlad broskdefekt 
läkte inte och visade jämförbar skada på motstående 
brosk jämfört med implantatbehandling. Alla im-
plantat växte fast. Får utvecklar broskskada med ål-
der, speciellt på knäets insida (mediala tibia). 
Slutsatser: Det utvecklade implantatsystemet visade 
sig säkert och pålitligt för reparation av små fokala 
ledskador hos får. Slitage på motstående ledbrosk 
kan accepteras om implantaten placeras i optimal 
position. Speciell intrumentering rekommenderas 
för detta, eftersom ett implantat aldrig får sticka ut. 
Kliniska studier av patienter med smärtsymptom re-
kommenderas. Ytterligare långtidsstudier av får eller 
patienter behövs innan profylaktisk operation kan 
rekommenderas.
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6.13 FUTURE PERSPECTIVES
”Fiction of today is the science of tomorrow”
Nicolas Martinez Carranza
                 
Every 45 second a total knee arthroplasty (TKA) 
is performed in the US, and by the year 2030 it is 
predicted that 3.5 millions TKAs will be performed 
each year in the US alone126. Another trend is that 
younger patients are receiving knee joint arthro-
plasty (unicompartmental or total), and this group 
performs inferiorly in terms of pain, function, mor-
bidity and prosthesis survival127-129. It is recognised 
that there is no correlation between pain and OA 
but there is a correlation between the different sta-
ges of OA and patient satisfaction after knee repla-
cement130. Hence, patients with early OA perform 
worse with knee arthroplasty (unicompartmental 
or total) compared to patients with advanced OA. 
Patients with early OA are often middle-aged and 
many of them have focal lesions with disabling 
symptoms similar to those scheduled for TKA113. 
These patients are ‘caught’ in a treatment gap: they 
are considered too young for TKA, and too old for 
biological treatments22. These patients present with 
symptoms that need to be treated, and their pro-
gression to OA needs to be stopped. The envisaged 
individualised patient oriented modular treatment 
of focal cartilage lesion of traumatic or degenerati-
ve origin proposed is an FKRM implant. Hopefully 
this could halt the OA progression, but should the 
disease progress, conversion to UKA is still possible. 
Should the OA progress a primary TKA would be 
the solution in non-responsive cases, and hopefully 
without requiring further revisions.
In order to treat younger patients with limited car-
tilage lesions or early OA by using FKRM implants 
more research is recommended. First, ethical per-
mission to define the normal cartilage condition in 
different joint surfaces and at different ages in sheep 
has been obtained. Data should be used to better 
understand and define the origin of focal lesions. 
Second, a well-powered long-term animal study is 
needed to assess the natural evolution regarding car-
tilage degeneration in the different knee compart-
ments, and analyse if early implant treatment could 
delay OA progression. Third, this treatment concept 
needs to be compared to other proven methods such 
as allographic osteochondral plugs, chondrocyte 
transplantation, tissue-engineered cartilage resurfa-
cing and common microfracturing. Fourth, a sys-
tem to assess cartilage health adjacent to an FKRM 
implant should be further developed and validated. 
Fifth, the assessment of the efficacy of FKRM im-
plants in humans in terms of improved pain and 
function, and the biological safety as determined 
by the long-term survivorship by entering standard 
national registries is needed. Finally, randomised 
clinical studies should compare FKRM results to 
non-treated lesions and other treatments moda-
lities in terms of pain, restored function and OA 
progression.
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